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PART I 
IR'l'RODUCTIOR 
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Alcohol (ethanol) is the most widely used of psychoactive 
drug and has been known in almost all civilizations since 
ancient times (Keller 1979). There are millions of people 
throughout the world who responsibly enjoy consuming 
alcoholic beverages served as food, medicines, and 
euphoriants. However, alcohol abuse, alcohol intolerance, 
alcohol dependence and other alcohol-related disabilities 
are some of the most challenging social, economical and 
public health problems facing our modern-day society. In 
the United states alone, the annual cost of lost 
productivitity and health expenses related to alcohol is 
estimated to be $117 billion (Hoek et al. 1992). 
Ethanol is known to cause a wide variety of metabolic 
abnormalities. Some of these abnormalities are the direct 
effect of ethanol while others are the result of ethanol 
induced malnutrition (Lieber 1991). Ethanol administration 
both in humans and laboratory animals, results in 
hyperlipidemia, fatty liver, and ultimately the most severe 
stage of alcoholic liver disease: scarring or cirrhosis of 
the liver. It has been recognized that the metabolism of 
ethanol plays a major pathogenic role in the etiology of 
various diseases associated with alcohol abuse. 
Approximately 90% of ingested ethanol is metabolized in the 
liver. The liver enzyme systems able to metabolize ethanol 
are; alcohol dehydrogenase (ADH), the microsomal ethanol 
oxidizing system (MEOS), and catalase (Larsen 195.9). 
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Carnitine (3-hydroxy-4N-trimethylammonium butyrate), an 
essential cofactor for facilitating fatty acid transport 
into the mitochondrial matrix is synthesized in all mammals, 
and consequently is present in diets containing meat 
products (Bieber 1988). Sachan et al. found that carnitine 
supplementation lowered ethanol-induced increases of various 
lipid fractions in rat's liver (Sachan and Rhew 1983, Sachan 
et al. 1984) in a dose related manner (Rhew and Sachan 
1986). They hypothesized a state of functional carnitine 
deficiency in chronic alcoholism and proposed that dietary 
carnitine supplementation may prevent ethanol-induced 
hepatic diseases. Further, they demonstrated that dietary 
carnitine supplementation elevated blood ethanol 
concentration (BEC) following both acute and chronic doses 
of ethanol and the increase in BEC was dependent on the 
level of carnitine supplementation (Berger and Sachan 1986, 
Sachan and Berger 1987, Berger and Sachan 1991, Sachan 
1992). This effect of carnitine is specific to carnitine 
since it could not be reproduced by choline (Sachan and 
Berger 1993). It was also shown that at 6 hours post 
ethanol administration on the third day of carnitine and 
ethanol treatment, there was significantly higher (96%) 
hepatic ethanol concentration (HEC) in the non-supplemented 
rats than in the carnitine supplemented rats without changes 
in activities of ethanol metabolizing systems (Mynatt and 
Sachan 1992, Sachan 1992). Those results suggested that 
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carnitine may modulate enzyme systems via some type of 
mediator or may be affecting membrane permeability to 
ethanol. 
The main objective of the first study, therefore, was to 
explore mechanism of carnitine-mediated attenuation of 
ethanol metabolism by: 
1. Determining the effects of carnitine on ethanol 
metabolism in isolated hepatocytes. 
2. Establishing specificity of carnitine inhibition on 
ethanol metabolism in the hepatocytes. 
The results of first study showed that, acetylcarnitine, a 
metabolite of carnitine, was a far more potent inhibitor of 
ethanol oxidation in hepatocytes than was carnitine. These 
results were encouraging in that it explained the lag time 
in carnitine response in the intact animal (Sachan 1992) and 
the lack of inhibition of ethanol metabolizing enzymes by 
carnitine (Mynatt and Sachan 1992). 
The main purpose of the second study, therefore, was to 
reinvestigate mechanism of carnitine-mediated attenuation of 
ethanol metabolism at the enzymatic level by: 
1. Determining the inhibitory effect of 
acetylcarnitine on ethanol metabolizing enzyme(s), 
ADH. 
2. Investigating the mechanism of acetylcarnitgwe 
interaction with ADH. 
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PART II 
LITERATURE REVIEW 
ETHANOL METABOLISM 
Ethanol is absorbed primarily from the small intestine 
(80%) by simple diffusion and is distributed throughout the 
total body water, accumulating in tissues with the highest 
water content (Goldstein 1983) . Studies with experimental 
animals have shown that the liver is the principal organ 
responsible for ethanol metabolism (Hawkins and Kalant 
1972) . The firs� step in the metabolism of ethanol is its 
oxidation to acetaldehyde. This conversion is carried out 
almost entirely in the liver, although other tissues have 
some oxidative capacity (2-10%) . Enzyme systems that can 
catalyze the oxidation of ethanol to acetaldehyde are 
alcohol dehydrogenase (ADH) , catalase, and the microsomal 
ethanol-oxidizing system (MEOS) (Li 1977, Branden et al. 
1975) . 
Liver ADH is a soluble enzyme that uses nicotinamide 
adenine dinucleotide (NAD+) as a coenzyme in conversion of 
ethanol to acetaldehyde according to the reaction shown 
below. The details are discussed in ADH review section 
(page 19) . 
Microsomal fractions of liver contains microsomal 
ethanol-oxidizing system (MEOS) , which can oxidize ethanol 
in the presence of molecular oxygen and NADPH. The 
8 
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mechanism involves cytochrome P-450 mediated hydroxylation 
of carbon one of ethanol with concomitant oxidation of NADPH 
(Lieber 1991) according to the following reaction. Lieber 
and.colleagues have characterized this system and believe 
that it is responsible for a substantial part of the ethanol 
metabolism in the liver, especially at high and chronic 
ethanol consumptions (Lie�er et al. 1987). In rats, chronic 
feeding of ethanol increases MEOS activity, hepatic 
microsomal protein, smooth endoplasmic reticulum, and 
cytochrome P-450 (Goldstein 1983). One possible explanation 
is that at low concentrations of ethanol, ADH is already 
saturated and at higher ethanol concentrations, the MEOS has 
the ability to oxidize more ethanol. This would be 
consistent with the known enzyme kinetics of the two systems 
since the Km for ethanol in ADH system is around 2 mmol. L-1 
and the Km for ethanol in the MEOS is around 10 mmol. L-1• 
Recently, P-450 IIEI which is a 52, 000 dalton protein, has 
been purified by immunoelectrophoresis and shown to be 
inducible by ethanol (Shimizu 1990). Since MEOS uses both 
NADP/NADPH and NAD/NADH coenzymes, ethanol oxidation via 
MEOS could result not only in accelerated ethanol 
metabolism, but it may also accelerate the ADH pathway by 
favoring the re-oxidation of NADH (Domschke et al. 1974). 
Catalase is a peroxisomal enzyme that can cata�yze the 
peroxidative cleavage of ethanol to acetaldehyde in the 
presence of a H202 generating system. The contribution of 
cataJuc 
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catalase in ethanol oxidation is quite small because the 
physiological rate of H202 production is rather low (Lieber 
et al. 1987, Li 1977) . However, there is evidence pointing 
to significantly larger than accepted rate of ethanol 
metabolism by catalase (Bradford et al. 1993) . 
The next step in the completion of ethanol oxidation is 
the oxidation of acetaldehyde to acetate catalyzed by 
aldehyde dehydrogenase (ALDH) . ALDHs are a group of enzymes 
catalyzing the conversion of aldehydes to corresponding 
acids via a NAD+-dependent irreversible reaction (Ikawa et 
al. 1983) . A more detail review of ALDH is given in the 
later section (page 19) . 
studies using liver perfusion, liver slices and 
hepatocytes have shown that acetate from ethanol is further 
metabolized in the liver. The [ 1-14C]-ethanol was partially 
recovered as 14C02 and TCA cycle intermediates (Dajani and 
Orten 1962, Forsander et al. 1965, Smith 1961) , indicating 
further oxidation of acetate in the liver rather than in the 
extrahepatic tissues. 
The incorporation of radioactive carbons of 14C-ethanol 
into acetoacetate, �-hydroxybutyrate, triglycerides and 
cholesterol indicates that acetate is also utilized for 
synthesis of these compounds in the liver (Smith 1961). 
EFFECTS OF ETHANOL OH LIVER 
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In the early part of this century, dietary deficiencies 
were considered to be the major cause of ethanol-induced 
liver diseases. However, even in the absence of dietary 
deficiencies ethanol can lead to the development of liver 
diseases in humans (Lieber et al. 1962). More recently, it 
has been shown that ethanol, as well as malnutrition which 
has been induced by ethanol, contributes to liver diseases 
(Lieber 1991). Because ethanol is rich in energy ( 7. 1 
Kcal. g-1 ), a large intake of ethanol has profound effects on 
nutritional status (Scheig 1970). over consumption of 
ethanol may cause primary malnutrition by displacing other 
nutrients in the diet because ethanol lacks essential 
nutrients other than calories (empty calories). Secondary 
malnutrition may result from either maldigestion or 
malabsorption of nutrients caused by gastrointestinal 
complications. Such primary and secondary malnutrition can 
induce deficiency of virtually all nutrients (Lieber 1990). 
Many disturbances in intermediary metabolism and toxic 
effects can be linked to (1) acetaldehyde, the product of 
ethanol oxidation, (2) ADH-mediated generation of NADH and 
(3) the induction of the microsomal enzymes, especially 
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P-450 IIEl (Lieber 1991) as shown in Figure 2.1. First, 
ethanol oxidation results in production of acetaldehyde 
which in turn, causes liver injury through a variety of 
mechanisms due to its nature of high chemical reactivity. 
Acetaldehyde causes glutathione depletion, lipid 
peroxidation (Lieber 1991), and stimulates hepatic collagen 
synthesis (Irving et al. 1991), thereby promoting fibrosis 
and cirrhosis. Second, ethanol oxidation in the cytoplasm 
via ADH results in a stoichiometric reduction of NAO+. 
Since the mitochondrial membrane is impermeable to NADH, 
reducing equivalents must be transferred into the 
mitochondria via the a-glycerophosphate or malate shuttle 
(Thurman 1977). The oxidation of ethanol in the hepatocyte 
increases the NADH/NAD ratio (Forsander et al. 1965, 
Domschke et al 1974). This increased NADH/NAD ratio is 
responsible for many of the deleterious effects of ethanol, 
such as ketosis, hyperlipidemia (Mendenhall 1972), 
hyperuricemia (Lieber 1962), and fatty liver (Lieber 1988). 
The activity of hepatic MEOS, especially, P-450 IIEl can be 
induced even after short-term and relatively light 
consumption of ethanol {Lieber et al. 1988). 
Induced cytochrome P-450 affects drug metabolism and 
enhances the rate of drug clearance from the blood (Kater et 
al. 1969). Ethanol pretreatment remarkably stimulates the 
toxicity and carcinogenicity of xenobiotics such as CC14 
(Hasumura et al. 1974) and bromobenzene {Hetu et al. 1983). 
PAUGS, STEROIDS 
Hf PATOTOXINS 
CAACIHOGENS 
- ::::::::,,�< .,_ UREA 
--·· �ACETATE 
PIGURE 2.1. oxidation of ethanol in the hapatocyte (Lieber 1991) 
... w 
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ETHANOL METABOLISM IN ISOLATED HEPATOCYTES 
Isolated, rat hepatocytes have been used for ethanol 
oxidation studies under controlled conditions. 
To relate the results of studies with isolated cells to 
ethanol metabolism in vivo, a major difference between 
isolated hepatocytes and the liver in vivo must be 
considered. A summary of many studies indicates that the 
rate of ethanol oxidation in rats in vivo is from 2. 4 to 4. 0 
µmol. min·1. g·1 of wet weight of liver (Cornell et al. 1977). 
In isolated rat hepatocytes, however, the rates are much 
lower from o. 7 to o. 9 µmol. min·1• g·1 of wet weight of cells 
when these cells are incubated with ethanol and no other 
substrate is added (Krebs & Stubbs 1975, Crow et al. 1978). 
Therefore, hepatocytes that are properly prepared and 
maintained provide an excellent in vitro system for studying 
liver ethanol metabolism because the isolated cells retain 
the same metabolic capacities as the intact liver (Cornell 
et al. 1977). Isolated hepatocytes are also a good system 
for studying ethanol metabolism in liver because the 
experimental conditions can be easily controlled. 
Effect of ethanol concentration 
Many studies have shown that a single large dose of 
ethanol increases the rate of ethanol oxidation in 
experimental animals (Yuki and Thurman 1980, Yuki et al. 
1980), and in vitro preparations of liver such as liver 
perfusion and hepatocyte preparation (Yuki et al. -1982). It 
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has also been shown in vitro that rat-liver parenchymal 
cells oxidized ethanol at a rate of 2. 5 µmol. min�. m�1 packed 
cells at 65 mmol. L-1 ethanol concentration, which was 1. 85 
times the oxidation rate at 4 mmol. L-1 ethanol. At ethanol 
concentrations above 10 mmol. L-1 a significant increase in 
the ethanol oxidation rate was observed compared to the 
oxidation rate at 4 mmol. L-1 (Grunnet et al. 1973) • This 
phenomenon has been named the "swift increase in alcohol 
metabolism". The increased oxidation rates attributed to 
the presence of a high-Km MEOS (Goldstein 1983). An 
accompanying increase in liver 02 uptake with large ethanol 
dose has also been observed (Yuki and Thurman 1980), which 
may be explained by the following sequence of events: 
ethanol increases the NADH redox state, which inhibits 
glycolysis because it is a NAD+ dependent pathway. since 
the glycolytic pathway is an ATP-generating sequence, 
inhibition of glycolysis makes more ADP available to 
stimulate mitochondrial electron transport, and increase 
oxygen uptake (Thurman 1977). In contrast to the above 
studies, other investigators have shown that ethanol is 
metabolized at a constant rate over a wide concentration 
range; however, a significant increase in 02 uptake is found 
after acute ethanol pretreatment in hepatocytes isolated 
from starved, but not from fed, rats (Stowell and crow 
1985). In one study ethanol was oxidized more slowly by 
rats which were given an ethanol dose of 5. 1 g. Kg� than by 
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rats which were given an ethanol dose of 1. 4 g. Kg·1 (Braggins 
and Crow 1981). This is not consistent with the previous 
explanation that a high Km MEOS and the rate of NADH 
reoxidation play an important role in determining ethanol 
oxidation rates and that the rates of ethanol metabolism are 
closely linked to the rates of 02 uptake. The alternate 
explanation is that ethanol was oxidized more slowly at high 
ethanol concentrations because ethanol itself was an 
inhibitor of rat liver ADH. It was also shown that 
increases in 02 uptake with ethanol pretreatment may not 
lead to an increased rate of ethanol metabolism. Therefore, 
the activity of ADH is the major factor limiting rates of 
ethanol oxidation in vivo (Braggins and Crow 1981). Some of 
these observations may be due to the different experimental 
conditions such as using different strain of animals, 
duration of starvation of rat, perfusion technique, 
incubation medium, etc. For example, the effects of ethanol 
on 02 uptake by liver depend entirely on the initial state 
of the liver. 
Fructose effect 
It has often been reported that fructose causes a marked 
acceleration of ethanol oxidation in perfused liver and 
isolated hepatocytes (Berry and Kun 1978, Grunnet et al. 
1973, Scholz and Nahl 1976). Scholz and Nahl (1976) have 
suggested that fructose accelerates ethanol oxidation by 
increasing the rate of intramitochondrial reoxidation of 
17 
NADH due to an increased ATP demand for gluconeogenesis. 
However, other gluconeogenic precursors such as sorbitol, 
which also increase respiration, have no stimulatory effect 
on ethanol oxidation. The stimulation of ethanol oxidation 
by fructose was completely abolished by 4 mmol. L-1 pyrazole 
(ADH inhibitor), indicating that the "fructose effect" was 
mediated via ADH (Berry and Kun 1978). 
Effects of pyruvate and lactate 
Pyruvate increased the oxidation rate of ethanol in 
isolated rat-liver cells by 130-240 % (Grunnet et al. 1973). 
_An apparent explanation for pyruvate induced acceleration in 
ethanol metabolism by isolated liver cells is the rapid 
reoxidation of cytosolic NADH via lactate dehydrogenase 
reaction which provides conditions more favorable for 
ethanol oxidation by ADH. By a similar reasoning, it might 
be expected that lactate added to hepatocyte suspensions 
would inhibit ethanol metabolism, since lactate oxidation 
produces NADH and competes with ADH for free cytosolic NAO+. 
It is well documented, however, that lactate increases 
the rate of ethanol oxidation in hepatocytes (Crow et al. 
1978, Krebs and Stubbs 1975). It has been suggested that 
substrates for glucose synthesis, such as lactate and 
pyruvate, accelerate ethanol oxidation, as a result of 
increased ATP utilization for glucose production 
(gluconeogenesis). Cornell et al. (1977) conducted 
experiments with quinolinate and tryptophan because these 
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compounds block gluconeogenesis in the rat by inhibiting 
phosphoenolpyruvate carboxykinase, thereby preventing 2/3 of 
the ATP utilization required in the synthesis of glucose 
from lactate or pyruvate (Ray et al. 1966, Veneziale et al. 
1967). They found that quinolinate and tryptophan both 
effectively decreased glucose synthesis, but neither 
inhibitor had any effect on the lactate or pyruvate 
stimulated rate of ethanol metabolism (Cornell et al. 1977). 
These results indicate that lactate or pyruvate stimulated 
oxidation is not due to an increased ATP demand for glucose 
synthesis. Alternatively, it has been proposed that lactate 
stimulation of ethanol oxidation in hepatocytes is due to an 
increase in malate and aspartate concentrations (Meijer et 
al. 1975) which would increase reoxidation of cytosolic NADH 
via the malate aspartate shuttle (Crow et al. 1983). 
In summary, the malate-aspartate shuttle (which controls 
reoxidation of NADH) intermediates may be rate determining 
step in ethanol metabolism by hepatocytes under some 
conditions (particularly in the fasted state) because 
shuttle intermediates (malate, glutamate, and aspartate) are 
lost during cell preparation (Cornell 1977, Krebs et al. 
1975), which is not the case in vivo. The rate of ethanol 
oxidation is limited by the level of cytosolic NADH which 
limits the rate of ethanol oxidation by ADH. 
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Alcohol dehydrogenase(ADR, EC 1.1.1.1) and Aldehyde 
dehydrogenase(ALDR, EC 1.2.1.3) 
ADH and ALDH are the major·enzymes involved in the 
initial two steps of ethanol metabolism. ADH is universally 
distributed in living organisms, occurring in 
·microorganisms, plants, and animals (Pietruszko 1983) . 
Yeast and mammalian alcohol dehydrogenase differ in 
substrate specificity and rate of catalytic activity 
(Branden et al. 1975) . In mammals, this enzyme occurs in 
highest concentration in the liver, where it is found in the 
cytoplasmic fraction (Raskin and Sokoloff 1972) . Liver ADH 
exists in multiple molecular forms that arise from the 
association, in various permutations, of different types of 
subunits (Strydom and vallee 1982) . Extrahepatic tissues 
contain isozymes of ADH with a much lower affinity for 
ethanol than the hepatic isozymes: as a consequence, at the 
concentrations of ethanol reached in the blood, the. 
extrahepatic enzymes are inactive, and therefore, 
extrahepatic metabolism of ethanol is negligible (Manautou 
and Carlson 1992) , with the exception of the 
gastrointestinal tract (Algar et al. 1992) . Human and 
rodent ADH exists as a heterogeneous group of isozymes that 
can be placed into three categories based upon structural 
and functional distinctions (Strydom and Vallee 1982) . 
Class I ADH is encoded in humans by three closely related 
genes ADHl, ADH2, and ADH3 showing differential tissue-
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specific and temporal expression during human development 
{Smith 1989). Class I ADH functions as both an ethanol 
dehydrogenase for detoxification of ingested ethanol {Li 
1977) and as a retinol dehydrogenase for retinoic acid 
synthesis {Mezey and Holt 1971). Ethanol is the classical 
human class I ADH substrate and acts as a competitive 
inhibitor of retinol oxidation in human liver extracts. 
Liver has consistently higher class I ADH activity than 
other tissues, whereas class III  ADH activity is present in 
practically all tissues {Danielsson et al. 1992). 
Human class II  ADH reduces an aldehyde intermediate in 
norepinephrine metabolism {Ooij et al. 1992). The 
distribution of class II isozymes changes between species. 
In humans, the class II  isozyme has been reported only in 
the liver, whereas in the rat, the ADH 2 isozyme is 
characteristic of the digestive tract and external organs 
such as skin, cornea, tongue, etc. , but is not found in the 
liver {Boleda et al. 1989). Human class III  ADH catalyzes 
an omega-oxidation step in leukotriene B4 synthesis in 
neutrophils {Gotch et al. 1990). Also, human class III  ADH 
has been identified as the glutathione-dependent 
formaldehyde dehydrogenase that is involved in elimination 
of formaldehyde produced as a by product of certain 
metabolic reactions {Jornvall et al. 1991). 
Rat tissues contain three different isozymes of ADH. Rat 
ADH 1 is an anodic isozyme present in high amount& in the 
21 
ocular tissues (Pares et al. 1985), stomach and lung. 
ADH 1 has intermediate properties, with a Km for ethanol of 
340 mmol. I;1 , a broad substrate specificity and Ki for 
pyrazol of 0. 56 mmol. I:1 • Rat ADH 2 is also anodic and has 
been found in all the rat organs examined (Julia et al 
1986). ADH 2 has substrate specificity for long-chain 
alcohols and aldehydes, cannot be saturated by ethanol and 
is practically insensitive to pyrazol (Ki=78. 4 mmol. L-1 ). 
Rat ADH 3 is the group of cathodic ADH's, are mainly present 
in the liver, and plays a major role in ethanol metabolism 
(Julia et al. 1987). ADH 3 exhibits a Km for ethanol of 1. 4 
mmol. I;1 , a broad substrate specificity and is strongly 
inhibited by pyrazole (Ki=0. 4 µmol. L�). There is 
approximately 80% sequence homology among subunits of human 
and rat liver ADH (Jornvall and Markovic 1972). Rat ADH 1, 
ADH 2 and ADH 3 exhibit many analogies with human .ADH 
classes II, III  and I respectively (Pares et al. 1985). In 
the rat, ADH 3 and to some extent ADH 1 are the primary 
isozymes for external alcohol metabolism whereas ADH 2 may 
be more important for the metabolism of the endogenous long­
chain alcohols and aldehydes (Julia et al. 1987, Julia et 
al. 1986). Human and rat isozymes are summarized in Table 
2. 1. In investigations of the interaction in vitro between 
liver ADH and a large number of heterocyclic compounds, 
pyrazol was found to be a most potent inhibitor of ADH. 
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TABLE 2.1 
Summary of human and rat ADB isozyaes 
Species Isoenzyme Location Specificity and 
function 
Human Class I Liver Ethanol oxidation 
Synthesis of 
retinoic acid 
Class II Liver Norepinephrine 
metabolism 
Class III All tissues Synthesis of 
leukotriene 
Rat ADH 1 Ocular Anodic 
Stomach High Km - ethanol 
Lung 
ADH 2 All tissues Anodic 
Long chain ethanol 
oxidation 
Insensitive to 
pyrazol 
ADH 3 Liver Cathodic 
Ethanol oxidation 
Inhibited by 
pyrazol 
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Pyrazole was shown to have a dose-dependent inhibitory 
effect on ethanol metabolism , ED� in the rat being 0. 29-
0. 4 3 m mol. kg·1 pyrazol ( Goldberg and Rydberg 19 69) • Studies 
in rats on the effects of various pyrazole analogues and 
other compounds on ethanol metabolism demonstrated that a 
dose of less than 0-5 mmol. L-1 pyrazol per kg resulted in an 
inhibition in the rate of ethanol elimination by more than 
25% of control value (Golfberg and Rydberg 1969). 
Therefore, pyrazole and its analogues are widely used to 
inhibit ADH and to block the metabolism of ethanol (Wendell 
-�nd Thurman 1979, Grunnet et al. 1973, Yuki et al. 1982, 
Feierman and Cederbaum 1987). The essential mechanism of 
action in vivo is most probably the same as the in vitro 
inhibition of the ADH. Pyrazole is a competitive inhibitor 
of ADH on ethanol oxidation, which is consistent with the in 
vivo findings that a dose-response relationship exists 
between degree of inhibition and dose of pyrazol (Goldberg 
and Rydberg 1969). Other inhibitors of ADH are summarized 
in Appendix 8. 
Like ADH, NAO-linked ALDH occurs primarily in the liver, 
with much lower concentrations in other organs. ADH occurs 
exclusively in the cytoplasm, whereas the ALDH activity is 
distributed among different subcellular compartment 
(Marjanen 1972). The majority of the ALDH activity in the 
rat is localized in the mitochondria, but the enzyme also 
occurs in the cytoplasm, microsomes, and other membranes. 
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Two major and several minor isozymes exist in the mammalian 
liver including man. One of the major isozymes, designated 
as ALDHl or El is associated with slower anodal 
electrophoretic mobility, a low Km for NAD, and a high Km 
for acetaldehyde. Another major isozyme, designated as 
ALDH2 or E2, is associated with faster anodal 
electrophoretic mobility, a high Km for NAO, and a low Km 
for acetaldehyde (Tottmar et al. 1973). ALDHl isozyme is of 
cytosolic origin and ALDH2 of mitochondrial origin (Vallari 
and Pietruszko 1984). 
There is some evidence that the interaction of alcohol 
and hormones may be mediated by ALDH (Maxwell and Topper 
1961). Ethanol has also been reported to cause alterations 
in the steady state levels of biogenic amines through 
alterations in the rates of ALDH metabolism of biogenic 
aldehydes (Tank et al. 1976). Thus, ALDH may play a 
physical role in the metabolism of aldehydes arising from 
corticosteroid and biogenic amine hormones. 
Although it is exceedingly rare in persons of European 
ancestry, in about 50-70 % of Orientals there is a 
deficiency of the ALDH enzyme (isozyme ALDHl) that 
metabolizes acetaldehyde to acetate (Goedde and Agarwal 
1983). The deficiency is responsible for high 
concentrations of acetaldehyde after the ingestion of 
ethanol. Acetaldehyde has pronounced effects on the body, 
including shortness of breath, facial warmth (flushing), 
decrease in blood pressure, and increase in heart rate 
(Agarwal and Goedde 1990). These effects of acetaldehyde 
are generally perceived to be·unpleasant, so it is easy to 
understand why this population, called flusher, become 
alcoholics far less frequently than nonflushers. 
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Disulfiram (Antabuse) and Calcium Carbamide (Temposil) 
are drugs that are sometimes given in the treatment of 
alcoholism (Giles and Kapur 1991, Pirola 1978). These drugs 
block the conversion of acetaldehyde by inhibiting ALDH 
enzyme (Giles and Kapur 1991). Drugs and chemicals that 
have disulfiram-like activity include cyanamide (Hald et al. 
1952), hypoglycemic sulphonylureas (Truitt et al. 1962), 
anti-parasitic agent, metronidazole, (Lal 1969), and 
antimicrobial drug, furazolidone, (Perman 1965). 
CARNITINE AND ETHANOL METABOLISM 
Carnitine facilitates the transport of fatty acids, via 
carnitine acyltransferase, into the mitochondria for�­
oxidation {Fritz et al. 1962). Without carnitine, most of 
the fatty acids that are eaten by humans could not be 
metabolized for energy and thus an important energy source 
would be eliminated and the fatty acids would be stored in 
adipose tissue (Bieber 1988). Because of the unique role of 
carnitine in the transport of fatty acids into mitochondria 
(Fritz et al. 1962) as well as among different organs 
(Hoppel et al. 1980), investigators studied the possibility 
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that carnitine might help prevent the ethanol-induced liver 
diseases. Hosein and Bexton (1975) reported that carnitine 
had a protective effect on lipid metabolism rat fed ethanol. 
They found that carnitine (0. 1 mg. g·1 B. W. ) significantly 
lowered serum triglycerides in rats which received ethanol 
(6 g. k�1 B. W. ). It also significantly reduced hepatic 
triglycerides in rats injected with ethanol 
intraperitoneally (4 g. kg-1 B. W. ). carnitine depletion in 
patients hospitalized for advanced cirrhosis was shown by 
Rudman et al. (1977). Fasting serum carnitine concentration 
was measured in 16 normal people and 247 cirrhotic patients. 
They found that the cirrhotic group showed significantly 
lower total and free carnitine than the normal group. 
In recent studies undertaken to study the possible effect 
of dietary carnitine supplementation on ethanol-induced 
hepatic steatosis, it was observed that carnitine 
supplementation lowered ethanol-induced increases of various 
lipid fractions ( Sachan et al. 1984, Sachan and Rhew 1983). 
They found that supplementation of carnitine in liquid 
alcohol diet (36 % calories as ethanol) significantly 
lowered total lipids, free and esterified cholesterol, 
triglycerides, and phospholipids in the liver. Later, it 
was found that the effect was dose dependent up to 0. 8 % of 
DL-carnitine supplement (Rhew & Sachan 1986). Intravenous 
administration of L-carnitine to humans significantly 
reduced ethanol-induced increase of blood acetate-and 
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promoted urinary excretion of acetylcarnitine following 
ethanol administration (Adamo et al. 1988). When rats were 
administered an acute oral dose of ethanol (Jg. Kg-1 B. W. ) , 
the animals supplemented with 1 % DL-carnitine for 3, 5, and 
10 days had significantly higher blood ethanol 
concentrations (BEC) from 2 to 8 hours post ethanol 
administration than non-supplemented rats (Berger and Sachan 
1986, Sachan and Berger 1987). The increase in BEC was 
dependent on the level of carnitine supplementation and the 
0. 5 % L-carnitine supplementation for 3 days produced 
maximum BEC (Berger and Sachan 1991, Sachan and Berger 
1993). They found that carnitine did not alter the rates of 
ethanol appearance in the portal blood, but it significantly 
elevated the systemic BEC during the same initial 30 min. 
So, they concluded that carnitine retarded ethanol 
metabolism without altering the rate of ethanol absorption 
from the small intestine. Since the simultaneous 
administration of carnitine with ethanol did not attenuate 
ethanol metabolism (Sachan 1992), it was proposed that 
carnitine may modulate enzyme systems or cell structure in 
some type of inductive manner (Mynatt 1989). Carnitine 
supplementation significantly reduced ( 1-14C]-.ethanol 
oxidation to Mco2 and increased plasma concentrations of 
lactate 2. 5 times which resulted in a higher 
lactate/pyruvate ratio. Carnitine supplementation, however, 
did not significantly affect the ethanol and acetaldehyde 
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metabolizing enzyme activities (Mynatt and Sachan 1992). 
The shift to a more reduced redox state by carnitine 
supplementation was hypothesized to be the possible 
mechanism for the attenuation of ethanol oxidation by 
carnitine. In conclusion, it was suggested that carnitine 
may modulate enzyme systems via some type of mediator or it 
may be affecting hepatocyte's permeability to ethanol. As a 
result ethanol oxidation in the isolated hepatocytes was 
examined to understand the mechanism of carnitine-mediated 
attenuation of ethanol metabolism. 
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METABOLISM IN RAT REPATOCYTES 
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ABSTRACT 
Previous studies have shown that supplementary carnitine 
protected liver from fatty infiltration caused by ethanol. 
One of the reasons was that carnitine retarded ethanol 
clearance and hence its metabolism in the intact rat. 
However, in vitro activities of ethanol metabolizing enzymes 
were not significantly altered by carnitine. Therefore, 
hepatocytes were targeted to understand the mechanism of 
action of carnitine on ethanol metabolism. The cells were 
isolated from male Sprague Dawley rats by a collagenase­
perfusion technique. Hepatocytes were incubated in albumin­
containing medium with ethanol in presence or absence of 
added L-carnitine or related compounds. Ethanol oxidation 
was determined by the loss of ethanol as well as by the 
products formed against time, cell numbers and ethanol 
concentrations. The rate of ethanol oxidation in presence 
of L-carnitine was one half the rate in absence of carnitine 
( 2 4. 69 nmol. min·•. million·1 cells) • Further it was found that 
choline mimicked carnitine effect and L-acetylcarnitine was 
100 times more active than L-carnitine in inhibiting ethanol 
oxidation in the isolated hepatocytes. The effect was dose 
related for both carnitine and acetylcarnitine, however, 
there was a definite lag time for carnitine effect. The 
products of ethanol oxidation in presence of acetylcarnitine 
suggested that site of inhibitory action must be ADH. From 
these results it is concluded that carnitine is converted 
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to acetylcarnitine which in turn inhibits ethanol metabolism 
in the isolated hepatocytes and the intact rat. 
INTRODUCTION 
Alcoholism is a major social, economical and public 
health problem throughout much of the world. In the United 
states alone, the annual cost of lost productivitity and 
health expenses related to alcoholism is estimated to be 
$117 billion (Hoek et al. 1992) . Alcohol (ethanol) is known 
to cause a wide variety of metabolic abnormalities (Agarwal 
and Goedde 1990) . Ethanol administration both in humans and 
laboratory animals results in hyperlipidemia and fatty liver 
(Lieber et al. 1987) . 
Carnitine (3-hydroxy-4-N-trimethylammonium butyrate) is 
widely distributed in living organisms and is biosynthesized 
in mammals. The foods of animal origin especially, milk and 
meats are rich dietary sources of carnitine. It is an 
essential cofactor for facilitating fatty acid transport 
into the mitochondrial matrix where �-oxidation takes place 
(Fritz et al. 1962) . Without carnitine, most of the 
ingested fatty acids would not be fully metabolized for 
energy and thus an important production, and the body would 
be forced to store the fatty acids as triglycerides in 
adipose tissue (Bieber, 1988) . 
In recent studies supplementary carnitine has been shown 
to minimize ethanol-induced hepatic steatosis in a dose 
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dependent manner (Sachan et al. 1984, Rhew and Sachan 1986). 
The underlying mechanism involved retarded clearance of 
blood-ethanol due to attenuation of ethanol metabolism in 
the intact rat (Berger and Sachan 1986, Sachan and Berger 
1987, Berger and Sachan 1991). This effect of carnitine is 
specific to carnitine since it could not be reproduced by 
choline (Sachan and Berger 1993). Further, it is known that 
hepatic ethanol concentrations are higher in carnitine 
unsupplemented than supplemented rats (Mynatt 1989). 
Carnitine reduced oxidation of 14C-ethanol to 14C02 in the 
intact rat, however, the in vitro activities of ethanol 
metabolizing enzymes were not significantly affected by 
carnitine (Mynatt and Sachan 1992). These results suggested 
that carnitine may modulate enzyme systems via some type of 
mediator or may be affecting membrane permeability to 
ethanol. 
Therefore, the main objective of this study was to 
explore mechanism of carnitine-mediated attenuation of 
ethanol metabolism using rat hepatocytes. The specific 
obj ectives were to determine in vitro effects of carnitine 
on ethanol metabolism in isolated hepatocytes and to 
establish specificity of the carnitine effect. Ethanol 
oxidation in rat hepatocytes was determined against time, 
cell numbers and ethanol concentration in presence or 
absence of L-carnitine as well as carnitine like compounds. 
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MATERIALS AND METHODS 
Chemicals. L-acetylcarnitine and r-butyrobetaine were 
obtained from Aldrich Chemical Co. (Milwaukee, WI). 
Collagenase (Type IV), HEPES (N-2-hydroxy ethylpiperazine), 
L-carnitine, DL-carnitine, choline, L-acetylcholine, P-OH­
butyrate, L-lysine, and palmytylcarnitine were purchased 
from Sigma Chemical Co. (St. Louis, MO). Bovine serum 
albumin (BSA) was obtained from ICN Pharmaceuticals, Inc. 
(Cleveland, Ohio). Ethanol was purchased from Quantum 
Chemical Co. (Tuscola, IL). Ethanolamine was obtained from 
Fisher scientific Co. (Fair Lawn, NJ). ( 1-14C] -ethanol was 
obtained from New England Nuclear (Boston, MA). All other 
chemicals were from Baxter Diagnostics Inc. (McGaw Park, IL). 
Animals and diets. The experimental protocol was 
approved by the University of Tennessee animal care 
committee. Male Sprague-Dawley rats (Harlan Sprague Dawley 
Inc. , Indianapolis, IN) with an average body weight . of about 
250 g were individually housed in 7" x 10" x 7" stainless 
steel wire mesh cages. Room temperature was maintained at 
22 °C  ± 1 °C  and constant relative humidity (52%) with a 12 
hour light-dark cycle. All specifications of the animal 
facility complied with AAALAC regulations. All animals had 
free access to rat chow (Agway Prolab #3000, Syracuse, NY) 
and hyperchlorinated city ,water. 
Hepatocyte preparation. About 8 : 30 A. M. on the day of 
experiment, a rat was anesthetized by Metofane (Pitman-
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Moore , Inc. Mundelein , IL). The abdominal cavity was opened 
and portal vein was surgically cannulated. The liver was 
perfused and hepatocytes were isolated according to the 
method described by Seglen (Seglen 1976) with some 
modification (Horne et al. 1976). The procedure is 
described in detail in appendix I. A brief account of the 
modification is as follow: The concentration of collagenase 
was 0. 05 % (w/v). ca+ +-free perfusion buffer for the 
preparation of the cells was replaced by the physiological 
saline Krebs-Henseleit buffer , KHB (Krebs 1974) and solution 
for the final incubation was replaced by KHB saline 
containing 2. 5% (w/v) BSA. The buffer solutions including 
collagenase buffer were gassed with 02: C02 mixture (95: 5) for 
at least 10 min and ca+ +  free buffer was gassed throughout 
the liver perfusion. The cells released by collagenase 
treatment were filtered though a nylon mesh (size 0. 5 mm x 
0. 3mm). All hepatocyte preparations were washed and - cell 
viability was determined by Trypan Blue exclusion (Crow et 
al. 1978). The hepatocyte concentration was standardized , 
kept at room temperature and used for study within hours 
after preparation. 
Ethanol metabolism in hepatocytes .  The incubation was 
carried out in a 25 mL Erlenmeyer flask in total volume of 4 
mL KHB (pH 7. 4) with 2. 5 % BSA. The hepatocytes in the 
incubation mixture was one million cells. mL"1 (24 million 
cells = 1 g wet cell weight). The standard incubation 
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mixture contained KHB with 2. 5 % BSA, hepatocytes (million. 
mL·1 ) , ethanol ( 10 mmol. L-1 ) , and carni tine or related 
compound (200 µmol. L-1 ) in 4 mL. Whenever necessary 
deviation in the concentration of component was made as 
indicated in that experiment. The flask was flushed with 
mix of 02: C02 (95: 5) before adding ethanol to get the 
predetermined concentration (usually 10 mmol. L-1 ) in the 
incubation mixture. The flask was sealed with rubber 
stopper and incubated in a Dubnoff water bath with shaking 
(80 oscillation. min�) at 37 °C. A control flask was 
prepared for each flask in which 0. 2 mL of 60% HC104 was 
added prior to addition of ethanol and rest of the 
incubation procedure was identical to that of test flask. 
The reaction was terminated by injecting 0. 2 mL of 60% HC104 
with a syringe. The contents were mixed well, and cooled in 
ice bath for 30 minutes. The mixture was centrifuged in a 
centrifuge (Backman TJ-6R, 2000 x g) at 4 °C  for 1o · minutes 
and supernatant was separated and assayed for ethanol by the 
enzymatic method (Bernt and Gutmann 1974). 
Oxidation of ethanol to CO2 was determined using ( 1-
14C ]  -
ethanol. The incubation was carried out on a 25 mL Warburg 
flask. The standard incubation mixture contained KHB with 
2. 5 % BSA, hepatocytes (million. mL-1 ) ,  [ 1-14C] -ethanol (10 
mmol. L-1 ) , and carni tine or related compound ( 2 oo  µmol. L-1 ) 
in 3 mL. Whenever necessary, deviation in the concentration 
of component was made as indicated in that experiment. The 
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center well contained 0 . 2  mL of ethanolamine (100 % )  and 
side arm contained 0 . 2 mL of 60 % HC104 • The flask was 
gassed with a mix of 02 : CO2 ( 9 5: 5) before adding 1 O mmol. L-1 
[ l-14C] ethanol. The flask was sealed with rubber stopper . 
Incubation was carried out at 37 ° C  in Dubnoff metabolic 
shaking water bath (80 oscillation . min� ) . The reaction was 
terminated by tipping HC104 from the side arm into 
incubation mixture . The flask was allowed to shake an 
additional 60 min at 37 °C  to allow absorption CO2 in the 
ethanolamine. The flask was well chilled in ice water for 
30 min. Ethanolamine was transferred from center well to 
scintillation vial. Residual ethanolamine was wash out 3 
times with scintillation fluid, 5 mL of scintillation fluid 
was added to the vial, and radioactivity was counted in a 
Beckman LS 3801 Liquid Scintillation system (14C02 ) • , The 
HC104 treated incubation mixture was centrifuged with in a 
Beckman TJ-6R tabletop centrifuge (2000 x g)  at 4 ° C  for 10 
minutes and SN, pellet were separated, and frozen for the 
analysis of metabolites. 
The pellet was extracted for Lipids with 2: 1 of 
chloroform-methanol mixture and insoluble substances were 
removed by pipetting out . Soluble mixture was washed with 
water 2 times to remove non-lipid contaminants, transferred 
into scintillation vial containing 5 mL of scintillation 
fluid, and radioactivity was determined in Beckman LS 3801 
liquid scintillation system . 
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Acetyl-CoA and acetylcarnitine were determined 
spectrophotometrically by the method (Pearson et al. 1974) 
described in detail in appendix 2. Acetate was determined 
by the enzymatic method using acetyl-CoA synthetase (Guynn 
and Veech 1975, Bridges et al. 1992) which is described in 
detail in appendix 3. Acetaldehyde was determined by the 
enzymatic method of described in detail in appendix 4 
(Lundquist 1974). Acetoacetate was determined by 
fluorescent spectrophotometric method of described in detail 
in appendix 5 (Mellanby and Williamson 1974). 3-
Hydroxybutyric acid was determined according to the 
procedure of Williamson and Mellanby (Williamson and 
Mellanby 1974) adapted for fluorescence which is in detail 
in appendix 6. 
All values shown in the figures and tables are expressed 
as group mean ± the standard error of the mean (SEM). The 
Student's t-test (Ott et al. 1987) was used to determine 
statistical significance of differences between the means of 
treatment groups at p s 0. 05. For the time course 
experiment, a split-plot-in-time model was used for 
analyzing the effects of time and treatment group on ethanol 
oxidation. A residual analysis indicated that using the 
natural logarithm transformation of ethanol oxidation data 
might be more appropriate than using normal ethanol 
oxidation data. Time, group, and their interaction were 
treated as fixed effects, rat nested within group was 
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treated as a random effect. Specific Linear Contrasts were 
used to test for differences in each group at the different 
time intervals. For the cell number experiment, a split­
plot model was used for analyzing the effects of cell number 
(1, 2, 3, 4, 8 )  and group (None and L-Carnitine) on ethanol 
oxidation. Group was considered the whole-plot, and cell 
number was considered the split-plot. A residual analysis 
indicated that no transformation of the data was necessary, 
so ethanol oxidation was analyzed directly. Cell number, 
group, and their interaction were treated as fixed effects, 
rat nested within group was treated as a random effect. 
Specific Linear Contrasts were used to test for differences 
in each group at the different cell numbers. For the 
ethanol concentration experiment, a simple two-way analysis 
of variance (without interaction) was used to analyze 
ethanol oxidation. A residual analysis indicated that no 
transformation of the data was necessary, so ethanol 
oxidation was analyzed directly. Ethanol concentration was 
considered as a fixed effect, and rat was considered a 
random effect. General Linear Mixed Models or GLMM (Blouin 
et al. 19�0) was used to analyze the data (time course, 
cell number, and ethanol concentration experiment). The 
GLMM was also used to calculate the Generalized Least Square 
Means (GLSM) and their SEM for the fixed effects in the 
model, variance components for the random effects, and the 
value of the specific contrasts. Data for all rats were 
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used in all three experiments (time course , cell number , and 
ethanol concentration) and no data were ignored. 
RESULTS 
Metabolic integrity of isolated hepatocytes was 
determined by studying the time course of ethanol oxidation 
(Figure 3. 1) as well as the effect of cell concentration 
(Figure 3. 2) and substrate (ethanol) concentration (Figure 
3. 3) on ethanol metabolism. Ethanol oxidation was linear 
with time for 60 minutes. Ethanol oxidation was also linear 
with cell numbers up to 8 million cells. The ethanol 
oxidation was increased in proportion to ethanol 
concentrations up to 4 mmol. L-1 at which maximum rate was 
reached and no increase was observed at higher ethanol 
concentrations. The Lineweaver-Burk plot of the data 
(Figure 3. 3 )' provided a Km of 1. 9 mmol. L-1 and Vmax of 11. 1 
mmol. L-1 • Ethanol oxidation in rat hepatocyte with and 
without L-carnitine is shown in Figure 3. 4. The rate of 
ethanol oxidation by rat hepatocytes without carnitine was 
24. 69 (nmol. min·1. million·1 cells) which is 43% higher than 
that the rate with L-carni tine ( 14. 05 nmol. min·1 • million·1 
cells). The time course of ethanol oxidation in hepatocytes 
with or without L-carnitine is summarized in Table 3. 1. 
There was a significantly decrease in ethanol oxidation by 
hepatocytes in the presence of L-carnitine within the first 
60 min. However , the inhibitary effect of carnitine was not 
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PXGURE 3 . 1 . Tia• course of ethanol oxidation by hepatocytes 
Values are mean ± SEM of 3 different hepatocyte preparations (3 
replicates from a single hepatocyte preparation and 1 replicate 
from each of the other 2 different hepatocyte preparations). 
Incubation mixture consisted of KHB pH 7 . 4  with 2. 5% BSA, 
hepatocytes (1 million. mL-1 ) ,  ethanol (10 mmol. L-1 ) ,  L-Carnitine 
( 2 oo  µmol. L·1 ) in a total volume of 4 mL. 
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PZGURB 3.2. Effect of hepatocyte concentration on ethanol 
oxidation 
Values are mean ± SEM of 3 different hepatocyte preparations (3 
replicates from a single hepatocyte preparation and 1 replicate 
from each of the other 2 different hepatocyte preparations). 
Incubation mixture consisted of KHB pH 7 . 4  with 2 . 5% BSA, 
hepatocytes (1 million. mL·1 ) ,  ethanol (10 mmol. L.1 ) ,  L-Carnitine 
(200 µmol. L.1 ) in a total volume of 4 mL .  
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FIGURE 3 .  3 .  Effect of ethanol concentration on ethanol oxidation·  
Values are mean ± SEM of 3 different hepatocyte preparations (3 
replicates from a single hepatocyte preparation and 1 replicate 
from each of the other 2 different hepatocyte preparations). 
Incubation mixture consisted of KHB pH 7. 4 with 2. 5% BSA, 
hepatocytes (1 million. mL-1 ) ,  ethanol (10 mmol. L-1 ) ,  L-Carnitine 
(200 µmol. L-1 ) in a total volume of 4 mL. 
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PXGURE 3 . 4 .  Effect of L-carnitine on ethanol oxidation by 
hepatocytes 
Values are mean ± SEM of 4 different hepatocyte preparations ( 3  
replicates from a single hepatocyte preparation and 1 replicate 
from each of the other 3 different hepatocyte preparations) .  
Incubation mixture consisted of KHB pH 7 . 4  with 2 . 5% BSA , 
hepatocytes ( 1 million . mL-1 ) , ethanol ( 10 mmol . L-1 ) , L-Carni tine 
( 2 00 µmol . L-1 ) in a total volume of 4 mL . 
Additions 
None 
L-Carnitine 
% Inhibition 
TABLE 3 . 1  
Tia• course of ethanol aetaholisa by hepatocytes1 
Incubation Time (min) 
15 30 60 9 0  120 
Natural Log (µmoles of ethanol metabolized per million� cells) 
0 .  01 ± 0 . 13• 0 . 65 ± 0 . 14• 
-o . 6 ± 0 . 13b O .  20 ± 0. 13b 
59 69 
1 .  37 ± 0 . 13• 
1. 01  ± 0 . 13b 
26 
1. 77 ± 0 . 13• 2 .  03 ± 0 . 14• 
1 .  68  ± 0 . 13• 1 . 9 4 ± 0 . 13• 
5 4 
1Values are mean ± SEM of 5 determinations from 3 different hepatocyte preparations (3 
observations/time for one rat and 1 observation/time for 2 other rats). 
Values bearing different superscript letters between rows are significantly differenrt 
(p s 0. 05). Incubation mixture consisted of KHB pH 7. 4 with 2. 5 % BSA, hepatocyte (1 
million. mL-1 ) ,  ethanol (10 mmol . L-1 ) ,  L-Carnitine (200 µmol . L·1 ) in a total volume 
of 4 mL. The precincubation period of 10  min preceeded start of reaction by addition of 
ethanol and incubation at 37 C for time intervals indicated in the table . 
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significant beyond 60 min. As a result the rates of ethanol 
oxidation by hepatocytes with L-carnitine was much lower 
than the rate without carnitine. Similarly, the effect of 
carnitine on ethanol oxidation by hepatocytes was greater at 
lower than at higher cell concentration (Table 3. 2). The 
inhibitory effect of carnitine on ethanol metabolism was 
significant at wide range of cell concentrations (0. 25-2 
million cells . mL·1 ) . 
The effect of carnitine and related compounds on ethanol 
oxidation is summarized in Table 3. 3. Ethanol oxidation was 
_significantly reduced by L-carnitine, DL-carnitine, choline, 
and L-acetylcarnitine compared to that without any addition. 
Choline had almost the same effect as carnitine on ethanol 
oxidation and equimolar DL-carnitine showed half the effect 
produced by L-carnitine. Most important, however, was the 
effect of acetylcarnitine which produced a much higher 
inhibition than did L-carnitine. 
The rate of ethanol oxidation in response to different 
concentrations (0. 2-40 µmol. �1 ) of L-carnitine and L­
acetylcarnitine is shown in Table 3 . 4. The maximum 
inhibitory effect of L-carnitine was at the concentration of 
2 o µmol. L·1 • In contrast, there was an almost identical 
inhibitory response by L-acetylcarnitine at the 
concentration of o. 2 µmol. L·1 • Thus, L-acetylcarni tine was 
a 100 fold better inhibitor of ethanol metabolism than was 
carnitine. 
TABLE 3 . 2  
Effect of hepatocyte concentration on ethanol aetabolisa1 
Additions 1 
None 1. 7 ± o. 35• 
L-Carnitine 1. 1 ± 0. 35b 
% Inhibition 35 
Hepatocyte Concentration (Millions. 4mL-1 ) 
2 3 4 
µ.moles of ethanol metabolized per hour-1 
4. 7 ± 0. 35• 
2. 8 ± 0 . 18b 
40 
7. 0 ± 0. 34• 
4. 2 ± 0. 33b 
40 
9 .  8 ± 0 .  35• 
6 .  0 ± 0. 35b 
3 9  
8 
17. 3 ± 1. 13•  
14. 7 ± 0. 35• 
15 
1Values are mean ± SEM of 5 determinations from 3 different hepatocyte preparations (3 
observations/hepatocytes for one rat and 1 observation/2 the other rats). 
Values bearing different superscript letters between rows are significantly different 
(p s 0. 05). Incubation mixture consisted of KHB pH 7. 4 with 2. 5 % BSA, hepatocyte (1-8 
million. mL4 ) ,  ethanol (10 mmol. L-1 ) ,  L-Carnitine (200 µ.mol. L-1 ) in a total volume 
of 4 mL. The precincubation period of 10 min preceeded start of reaction by addition of 
ethanol and incubation at 37 c for 60 min. 
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TABLE 3.3 
Effect of carnitine and related compounds on ethanol metabolism in hepatocytes 
Additions Ethanol Metabolism Change 
[ 2 oo µmol. L-1 ] (nmol. min-1 • million-1 cells) ( % ) 
None 37. 1 ± 1. 17 0 
L-Carnitine 27. 3 ± 1. 4 4  -26. 5 
DL-Carnitine 31. 4 ± 0. 58 -15. 4 
Choline 27. 2 ± 0 . 23 -26. 7 
r-Butyrobetaine 42. 8 ± 2. 31 15. 4 
�-OH-Butyrate 41. 2 ± 1. 79 11. 0 
L-lysine 37. 9 ± 0. 89 2. 2 
L-Acetylcarnitine 2 4 . 4  ± 0. 4 6  -34. 2 
Palmytylcarnitine 42. 0  ± 1. 79 13. 2 
1Values are mean ± SEM of 3 determinations from 2 different hepatocyte preparations. 
Incubation mixture consisted of . KHB pH 7. 4 with 2. 5 % BSA, hepatocyte ( 1 million. mL-1 ) ,  
ethanol (10 mmol. L-1 ) ,  L-Carnitine or related compounds ( 200 µmol . L-1 ) in a total 
volume of 4 mL. The precincubation period of 10 min preceeded start of reaction by 
addition of ethanol and incubation at 37
°
C for 60 min. "' • 
TABLE 3 . 4  
Effect of carnitine and acetylcarnitine concentration on ethanol metabolism in hepatocytas1 
Additions 
None 
L-Carnitine 
L-Acetylcarnitine 
0 
4 9 . 0  
concentration (µmol . L·1) 
0 . 2  0 . 5  1 3 6 12 
Ethanol Oxidation (nmol. min·1• million·1 cells) 
27. 5 
8 . 0  
26 . 0  
8 . 0  
26 . 0  
9 . 0  
15. 5 
11. 5 
14 . 5  
11. 0 
11 . 5  
13 . 0  
1Values are mean of 2 determinations from a single hepatocyte preparation . 
20 
8 . 0  
15 . 0 
4 0  
8 . 0  
14 . 2  
Differnent hepatocytes from different rat gave similar results. Incubation mixture 
consisted of KHB pH 7 . 4  with 2. 5 % BSA, hepatocyte (1 million. m�1), ethanol (10 
mmol . L-1 ) ,  L-Carnitine or L-Acetylcarnitine (200 µmol. L-1 ) in a total volume of 4 mL . 
Incubation period was 20 min at 37
°
C .  
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The products of ethanol oxidation by hepatocytes with and 
without L-carnitine and L-acetylcarnitine is shown in Table 
3. 5. The metabolism of ethanol was determined by the rate 
of ethanol disappearance from the medium as well as by the 
products of ethanol oxidation. There was good balance 
between ethanol disappearance and the products formed. The 
major (93-95 %) product of ethanol metabolism was CO2 • The 
remaining 4 % were other intermediates of ethanol metabolic 
pathway. Therefore, the major impact of carnitine or 
acetylcarnitine inhibition was in terms of CO2 produced. A 
small but quite relevant effect could be appreciated in 
concentration of acetaldehyde in presence or absence of 
these inhibitors. 
DISCUSSION 
The carnitine-mediated attenuation of ethanol metabolism 
in the intact rat formed the basis for studying the . 
mechanism at cellular level. The rate of ethanol oxidation 
by hepatocytes in our study was about 33 nmol . min-1. million-1 
hepatocytes which is approximately o. 8 µmol. min1 • g-1 of wet 
cell weight or 24 million cells. These rates are within the 
range reported ( O .  7-0. 9 µmol. min-1. g-1 ) for rat hepatocytes 
in presence of no other substrate but only ethanol (Krebs 
1975, Crow et al. 1978). These rates of ethanol oxidation 
in isolated hepatocytes are about 70-78% lower than those 
( 2. 4 - 4. o µmol. min-1 • g-1 of wet weight of liver) observed 
TABLE 3 . 5  
Effect of carnitina and acatylcarnitine on ethanol aetabolisa aeasured by ethanol 
disappearance and product foraation1 
Ethanol 
Disappeared2 : 
Product formed3 : 
t4co2 
14C-Fatty acids 
Acetaldehyde 
Acetyl-CoA 
Acetylcarnitine 
Acetate 
Acetoacetate 
3-hydroxybutyrate 
Recovery ( % ) 
None L-Carnitine L-Acetylcarnitine 
Ethanol Metabolism (nmol . min·1 • million·1 cells) 
34. 6 ± 3 . 0  27 . 9  ± 2 . 0 22 . 4  ± 0 . 6 
3 0 . 03 24 . 27 18 . 4 4 
28 . 0  ± 2 . 1 23 . 2  ± 1 . 6 17 . 6  ± 0 . 1 
0 . 27 ± 0 . 05 0 . 12 ± 0 . 06 0 . 11 ± 0 . 09 
1 . 5 ± 0 . 06 0 . 6 ± 0 . 03 0 . 3 ± 0 . 06 
0 . 13 ± 0 . 01 0 . 1 ± 0 . 01 0 . 1 ± 0 . 01 
0 . 13 ± 0 . 02 0 . 2  ± 0 . 01 0 . 27 ± 0 . 01 
86 . 8  86 . 9  82 . 3  
1Values are mean ± SEM of 3 dete�minations from a single hepatocyte preparation . 
2
•3Incubation mixture consisted of KHB pH 7 . 4 with 2 . 5 % BSA, hepatocyte (1 million . mL-1 ) ,  
( 1-14C ] -ethanol (10 mmol . L-1 ) ,  L-Carnitine or L-Acetylcarnitine (200 µmol . L·1 ) in a 
total volume of 3 mL . Incubation period was 20 min at 37
°
C .  
UI 
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in intact rat (Sachan 1992, Sachan and Berger 1987, Berger 
and Sachan 1991) and in several in vivo studies summarized 
by others (Cornell et al. 1977). The decrease in oxidation 
rate of ethanol in isolated hepatocytes is due to loss of 
shuttle intermediates during hepatocyte preparation, since 
addition of malate and/or lactate restored the rates of 
ethanol oxidation in isolated hepatocytes equal to that 
found in the intact liver (Cornell 1974, Krebs et al. 
1975). 
Ethanol oxidation in isolated hepatocytes was linear with 
�ime (Figure 3. 1), cell numbers (Figure 3. 2) and ethanol 
concentration (Figure 3. 3). The data produced a classical 
Michaelis-Menten kinetic with a Km = 1. 9 mmol. L-1 and V = max 
11. 1 mmol. L-1• The Km for ethanol is slightly higher than 
the Km ( 1. 4 mmol. L-1) reported for rat liver ADH-isozyme 3 
which is the primary isozyme for ethanol metabolism in rat 
(Julia et al. , 1987). In our hepatocyte preparations, 
ethanol oxidation maximized at ethanol concentration of 
4mmol. L-1 which is similar to that seen in parenchymal cells 
of 24 hour starved female Wistar rats (Grunnet et al. 1973). 
Hepatocytes from .fed male Sprague Dawley rats ethanol 
metabolized at a constant rate at high ethanol concentration 
(Stowell and Crow 1985) which is in concert with our data. 
Carnitine inhibited ethanol oxidation in hepatocytes 
(Figure 4 and Table 3. 1-3. 2) which is consistent with the 
observations in the intact rat (Sachan 1992). The magnitude 
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of inhibition of ethanol metabolism was about 50% in 
isolated hepatocytes and about 30% in the intact animal 
(Sachan and Berger 1986, Mynatt and Sachan 1992). The 
inhibitory effect was not limited to carnitine alone in 
hepatcocytes since equimolar concentations of choline was 
equally effective in decreasing ethanol oxidation (Table 3). 
In the intact rat, choline did not inhibit ethanol 
metabolism (Sachan and Berger 1993). The most important 
finding was that acetylcarnitine at concentrations equal to 
that of carnitine was far more potent inhibitor of ethanol 
metabolism in hepatocytes (Table 3. 3) . A dose response 
study revealed acetylcarnitine to be 100 times more 
effective than carnitine alone (Table 3. 4). While response 
to carnitine was preceded by a short lag time, the effect of 
acetylcarnitine was immediate. This is born out by the data 
in intact rat where simultaneous administration of carnitine 
and ethanol did not attenuate ethanol metabolism and a 
minimum period of about 32 hours was essential before effect 
of carnitine was seen (Sachan 1992). A 11-15% stimulation 
of ethanol oxidation by butyrobetaine, P-hydroxybutyrate and 
palmitylcarnitine is interesting and needs further study. 
About 95% of ethanol was oxidized to CO2 and remaining 
was found as acetaldehyde, acetyl-CoA, acetylcarnitine and 
lipids etc. (Table 3. 5). Carnitine and acetylcarnitine 
reduced these products 20% and 40%, respectively. since, 
acetaldehyde formation was especially decreased by the two 
inhibitors , it suggested inhibition of ADH. 
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PART IV 
EFFECT OF L-CARNITINE AND L-ACETYLCARNITINE ON 
ETHANOL METABOLIZING ENZYMES 
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ABSTRACT 
Since acetylcarnitine, a metabolite of carnitine, proved 
to be a .potent inhibitor of ethanol oxidation in hepatocytes 
(Chapter II I), the main objective of this study was to 
determine effects of acetylcarnitine on ethanol metabolizing 
enzyme (s). Because 90% of ethanol oxidation is oxidized via 
ADH pathway, this enzyme was targeted for potential 
inhibitory effects of acetylcarnitine, carnitine and related 
compounds. The post-microsomal supernatant (PMS) was 
prepared from normal male Sprague Dawley rats by 
differential centrifugation and used for determination of 
ADH activity in the presence or absence of carnitine 
derivatives. It was found that the inhibition of ADH 
activity occurred only when NAD concentration was less than 
the inhibitor concentration. As NAD concentration was 
decreased, inhibition by acetylcarnitine was significantly 
(67%) increased. Carnitine, choline, and acetylcholine were 
very weak inhibitors of ADH. Inhibition of ADH activity by 
acetylcarnitine produced a typical Michaelis-Menten kinetics 
(Ki = 135 µmol. I;1) and the Lineweaver-Burk plot revealed 
that inhibition was of competitive nature. Binding studies 
showed that acetylcarnitine did bind to ADH in a dose 
related manner provided NAD: acetylcarnitine ratio was low. 
The MEOS activity was not affected by acetylcarnitine or 
carnitine. Both crystalline and crude ADH preparations from 
different vertebrate species were also inhibited by 
6 5  
acetylcarnitine ; however, the yeast enzyme was unaffected . 
It is concluded that attenuation of ethanol metabolism is 
mediated via the inhibition of ADH by acetylcarnitine under 
diminishing concentrations of NAO+ . 
INTRODUCTION 
Ethanol has a wide variety of short- and long-term 
effects on human physiology (Hawkins and Kalant 1972) . 
Ethanol oxidation occurs primarily in the liver by ADH, 
MEOS, and catalase (Lieber, 1991) . ADH catalyzes the 
oxidation of a wide variety of xenobiotic or endogenous 
alcohols (Duester 1991, Eklund et al . 1990) . In addition to 
the rate-limiting step in ethanol metabolism (Li 197 7), 
human class I ADH catalyzes vitamin A (retinol) oxidation 
(Mezey and Holt 197 1), which is the rate-limiting step in 
the conversion of retinol to retinoic acid . Retinoic acid 
has been called a hormone like substance because it . 
modulates transcription via specific nuclear receptor 
(Petkovich et al . 1987, Wahli and Martinez 1991) . 
Mammalian ADHs are polymorphic and the isozymes can be 
classified based on their function and physicochemical 
properties (Julia et al . 1987, Strydom and Vallee 1982) . It 
has been found that isozyme ADH 3 is the enzyme responsible 
for ethanol oxidation in rat liver . It has a Km of 1 . 4  
mmol . L·1 for ethanol and Ki of o .  4 µmol . L-1 for pyrazole 
(Julia et al . 1987) .  
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The role of MEOS in ethanol metabolism has been 
controversial . However, following chronic abuse and high 
doses of ethanol, contribution of MEOS to total ethanol 
oxidation increases significantly (Lieber, 1987) . The 
peroxidation of ethanol by catalase is limited by the rate 
of H202 formation which, under physiological conditions, 
would be too low to contribute significantly to total 
ethanol oxidation (Li 1977, Lieber et al . 1987, Hawkins and 
Kalant 1972) . 
Carnitine (J-hydroxy-4N-trimethyl ammonium butyrate) is 
an essential cofactor for facilitating fatty acid transport 
into the mitochondrial matrix where P-oxidation takes place 
(Murthy and Pande 1984) . It was this role of carnitine that 
first prompted investigators to study the possibility that 
carnitine might help prevent the ethanol-induced hepatic 
steatosis . In a chronic alcohol feeding trial (36% calories 
as ethanol), carnitine prevented ethanol-induced 
accumulation of total lipids, free and esterified 
cholesterol, triglycerides and phospholipids in the liver 
and the effect was dose related (Sachan and Rhew, 1983, 
Sachan et al . 1984, Rhew and Sachan 1986) . 
Carnitine offered this protection by retarding ethanol 
clearance due to attenuation of ethanol metabolism under 
both acute and chronic conditions of ethanol administration 
(Berger and Sachan 1986, Sachan and Berger 1987, Berger and 
Sachan 1991, Sachan and Berger 1993) . Further, oxidation of 
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orally administered ( 1-14C] -ethanol to 14C02 was significantly 
reduced 4-12 hours following ethanol administration in the 
carnitine supplemented intact rats. However, in vitro 
activities of ADH, MEOS, catalase and acetaldehyde 
dehydrogenase were not significantly altered by carnitine 
(Mynatt and Sachan 1992, Sachan 1992). since plasma 
concentrations of lactate were increased 2. 5 fold in the 
carnitine supplemented rats after ethanol administration, 
the explanation was that carnitine attenuated ethanol 
oxidation by causing a large shift in the redox state of the 
system (Mynatt and Sachan 1992). 
In the part III, we have shown that acetylcarnitine is a 
more potent inhibitor of ethanol oxidation in hepatocytes 
than was carnitine. Therefore, the purpose of this study 
was to determine potential inhibitory effect of 
acetylcarnitine on ADH and MEOS. The purified (commercial) 
and semipurified (PMS, microsomes) enzyme preparations were 
used for these studies. 
MATERIALS AND METHODS 
Chemicals . 14C-acetyl-CoA was purchased from Moravek 
Biochemicals, Inc . (Brea, CA). L-acetylcarnitine and r­
butyrobetaine were obtained from Aldrich Chemical Co. 
(Milwaukee, WI). L-carnitine, DL-carnitine, choline, L­
acetylcholine, P-OH-butyrate, L-lysine, gamma­
aminobutyrate, Folin & Ciocalteu's phenol reagent, NAD 
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(Grade III), ADH (Bakers Yeast), NADPH (Tetrasodium Salt), 
Glutathione (reduced form), and palmitylcarnitine were 
purchased from Sigma Chemical Co. (St. Louis, MO). Bovine 
serum albumin was obtained from ICN Pharmaceuticals, Inc. 
(Cleveland, Ohio). Ethanol was purchased from Quantum 
Chemical Co. (Tuscola, IL). All other chemicals were from 
Baxter Diagnostics Inc. (McGaw Park, IL). 
Animals and diets . The experimental protocol was 
approved by committee on Humen Care and Use of Laboratory 
Animals. Male sprague-Dawley rats (Harlan Sprague Dawley 
Inc. , Indianapolis, IN) with an average body weight of 200 g 
were individually housed in 7" x 10' x 7' stainless steel 
wire mesh cages. Room temperature was maintained at 22 ° C  ± 
1 °C  and constant relative humidity (52%) with a 12 hour 
light-dark cycle. All specifications of the animal facility 
complied with AAALAC regulations. All animals had free 
access to rat chow (Agway Prolab #3000, Syracuse, NY) and 
chlorinated city water. 
Enzyme preparation . On the day of experiment, at 8: 30 
A . M . ,  liver of a rat was surgically cannulated and perfused 
with cold o . 15 M KCl in O .  01  mol. L-1 phosphate buffer, pH 
7. 4. The liver was homogenized in ten volumes of KCl­
phosphate buffer, pH 7. 4, in a teflon/glass homogenizer. 
The homogenate was centrifuged at 600 x g for 10 minutes at 
2 °C in a  Beckman J2-21M induction drive centrifuge (Beckman 
Instruments, Inc. , Palo Alto, CA). The 600 x g supernatant 
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(SN) was carefully transferred to another centrifuge tube 
and centrifuged at 10, 000 x g for 10 min. The 10, 000 x g SN 
was centrifuged at 100, 000 x g for 1 hr. at 4 °C in a  L5-50 
Ultracentrifuge. An aliquot of the PMS was then saved and 
used for ADH analysis and 100, 000 x g pellet (microsomes) 
was suspended in KHB (pH 7. 4) and used for determination of 
MEOS. Protein concentration in the PMS and microsomes was 
determined using Falin & Ciocalteu's phenol reagent (Lowry 
et al. 1951). 
Determination of ADH activity . ADH activity was estimated 
by using a modified procedure of Bergmeyer (Bergmeyer et al. 
1974). Each reaction was performed in a total volume of 3 
mL at 37 °C. The components and final concentration in the 
reaction mixture were sodium pyrophosphate buffer (55 
mmol. L·1 ), pH 7. 4, ethanol (20 mmol. L-1 ) , NAD+ ( o. 2-2 mmol. L· 
1 ), reduced glutathione (1. 1 mmol. L-1 ), semicarbazide (55 
mmol. L-1 ), glycine (1. 6 mmol. L-1 ), and enzyme preparation (2-3 
mg SN protein). Whenever necessary deviation in the 
concentration of a component was made as it is indicated in 
that experiment. The reaction mixture was preincubated for 
3 minutes at 37 °C in a  temperature controlled Beckman Model 
34 dual-wavelength spectrophotometer. The reaction was 
initiated with the addition of ethanol and absorbance at 340 
nm was recored for at least 3 minutes. 
Ethanol oxidation by MEOS . It was determined using a 
modified procedure of Lieber (Lieber and Decarli 1970). 
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Flasks were divided into three groups; (a) no inhibitor, (b) 
with 200 µmol. �1 L-carnitine or (c) 200 µmol. �1 L­
acetylcarnitine. Each reaction was performed in a total 
volume of 3 mL at 37 °C in a  25 mL Erlenmeyer flask. The 
components and final concentration in the reaction mixture 
were Na2HP04/KH2P04 buffer ( 100 mmol. L·
1 ) , pH 7. 4, MgC12 ( 5. o 
mmol. L-1 ) , disodium-EDTA ( 1. 0 mmol. L·1 ) ,  NADPH + H+ ( 1 mmol. -
1 ) ,  ethanol (10 mmol. L-1 ) ,  and enzyme preparation (8-10 mg of 
microsomal protein) . The NADPH + H+ and ethanol were added 
last. Following NADPH + H+ addition the flask was flushed 
-with 02+C02 (95: 5) for 20 seconds and the reaction was 
started by adding ethanol. The flask was stoppered with a 
serum cap and incubated in a shaking (80 oscillations/ min) 
water bath at 37 °C  for 120 min. A control flask was 
prepared for each test flask in which 0. 2 mL 60% HC104 was 
added and contents mixed prior to oxygenation and addition 
of ethanol and incubation. The reaction in test flasks was 
terminated by injecting 0. 2 mL of 60% of HC104 with a 
syringe and mixing the contents which were then cooled for 
3 0  min in ice bath. The reaction mixture was centrifuged at 
2000 x g for 10 min and SN were assayed for ethanol 
concentration by an enzymatic method (Bernt and Gutmann, 
1974 ) . 
Acetylcarni tine binding assay . ( 1-14c] -acety lcarni tine 
was synthesized according to the method described in 
appendix 7 (Murthy and Pande 1984) . In a 1. 5 mL micro 
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centrifuge tubes (conical bottom with attached closure) the 
total volumes of 0. 5 mL contained sodium pyrophospate 
buffer, pH 7. 4 (55 mmol. L-1 ), NAD+ ( O ,  1, 2, and 4 µmol. L-1 ), 
reduced glutathione ( 1. 1 mmol. L-1 ) , ( 1-14C]-acetylcarni tine ( 2 
µmol. L-1 , specific radioactivity 123, 659 dpm. nmo1e·1 or 2061 
Bq. nmole) , and horse ADH (0. 17 IU or 100 µg protein) . The 
ratio of (NAD] : [ 14C-acetylcarnitine] in each tube was 
controlled by adding different NAD concentration stated 
above resulting in NAD : ( 1-14C]-acetylcarnitine ratio of o, 
0. 5, 1, and 2 (see Appendix 7) . The reaction mixture was 
incubated for 5 minutes at 37 °C in a  Dubnoff metabolic 
shaking water bath (80 oscillation. min-1 ) .  The reaction 
mixture was then transferred to an 30, 000 NMWL Ultrafree-MC 
filter unit (Millipore, Bedford, MA) and centrifuged at 
maximum speed (15, 000 x g) for 5 min in an Eppendorf 
centrifuge, model 5412 (Sybron/Brinkmann Instruments, 
Westbury, NY) . The residue on membrane sample cup was 
transferred to a scintillation vial containing 5 mL 
scintillation fluid and the radioactivity was counted in a 
Beckman LS 3801 Liquid Scintillation counter. 
All values are expressed as group mean ± SEM. The 
student ' s  t-test (Ott et al. 1987) was used to determine 
significant differences between the means of two groups at 
the level of p< 0. 05. When 2 or more treatments were 
compared, an ANOVA was employed and followed with a Duncan ' s  
Multiple Range Test (Steel and Torrie 1960) . 
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RESULTS 
Under the standard conditions of ADH assay , carnitine or 
acetylcarnitine did not affect ADH activity (Table 4. 1) . 
However , when NAO+ concentration was made limiting , ADH 
activity was significantly inhibited by acetylcarnitine 
which was inversely related to the ratio of 
NAD+: acetylcarnitine (Table 4. 2) . Inhibition by carnitine 
and choline was less than 5% compared to 45% by 
acetylcarnitine. The inhibition by acetylcholine ranged 
from 2-17% depending on the ratio of NAD: acetylcholine. 
The inhibitory effect of acetylcarnitine (22%) was specific 
as other compounds inhibited ADH activity little (3-10%) or 
none under identical conditions (Table 4. 3) . Effect of 
various acetyl derivatives on ADH activity is summarized in 
Table 4. 4. At equimolar concentration and at NAD: acetyl 
derivative ratio of 1: 2 ,  inhibition of ADH was 28% by 
acetylcarnitine , 10% by acetylcholine or acetylCoA , . s% by 
ammonium acetate and 5% by sodium acetate. Carnitine and 
choline inhibited ADH activity of 4% and 5% , respectively. 
As shown in Table 4. 5 ,  the oxidation of ethanol by MEOS was 
not affected by carnitine or acetylcarnitine under the 
standard conditions. 
The effects of two concentrations of acetylcarnitine at 
various concentrations of NAD+ on the activity of ADH is 
shown in Table 4. 6 and Figure 4. 1. Either concentration of 
acetylcarnitine produced greater inhibition of ADH at lower 
TABLE 4 . 1  
Effect of carnitine and acetylcarnitine on ADH activity• 
Inhibitors 
( 200 µmol. L·1 ] 
None 
L-Carnitine 
L-Acetylcarnitine 
ADH Acti vi ty2 
( nmoles NADH. min·1 • mg·1 ) 
5. 11 ± 0. 05 
5. 21 ± 0. 03 
5. 40 ± 0. 03 
1Conditions: 3 mL of reaction mixture contained sodium 
pyrophosphate buff er ( 55 mmol. L-1 ) , pH 7. 4, NAD ( 2 mmol. 
L-1 ) ,  reduced glutathione (1. 1 mmol. L-1 ) ,  enzyme 
(mg SN protein) and inhibitor (200 µmol. L-1 ) .  
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The reaction mixture was preincubated for 3 min at 37 °C 
before starting reaction by addition of ethanol (20 mmol. 
L-1 ) .  Absorbance was monitored at 340 nm for at least 3 min. 
2Values are the means ± SEM of 3 determinations. 
TABLE 4 . 2  
Effect of carnitine, choline, acetylcarnitine, and acetylcholine on ADH activity different 
RAD concentration1 
Inhibitors 
None 
L-Carnitine 
Choline 
L-Acetylcarnitine 
L-Acetylcholine 
25 
[ 1: 8 ] 2 
NAO concentration ( µmol. L-1 ) 
50 
[ 1: 4] 
100 
[ 1: 2 ] 
200 
[ 1: 1] 
ADH Activity (nmoles NAOH. min·1• mg-1) 3 
0. 96±0. 005aw 
0 . 92±0. 017aw 
(4. 06)4 
0. 92±0. 0l71w 
( 4. 06) 
0. 53±0. 005bw 
(45. 20) 
0. 83±0. 012cw 
(13. 23) 
1. 84±0. 012ax 
1. 80±0. 17° 
(2. 38) 
1. 75±0. 012° 
(4. 78) 
1. 20±0. 012bx 
(40. 49) 
1 • 6 2 ± 0 • 0 2 3 bx 
(11. 89) 
2. 68±0. 005•1 4. 78±0. 005az 
2. 41±0. 029by 4. 69±0. 035az 
(9. 83) (1 . 84) 
2. 58±0. 005•1 4. 69±0. 0l7az 
(3. 29) (1. 84) 
1. 93±0. 005by 4. 43±0. 017bz 
(27. 89) (7. 38) 
2. 23±0. 005by 4. 69±0. 012az 
(16. 71) (1. 84) 
1Conditions: 3 mL of reaction mixture contained sodium pyrophosphate buffer (55mmol. Ii1 ) ,  
pH 7. 4, NAO (25-200 µmol. L-1 ) ,  reduced glutathione (1. 1 mol. L-1 ) ,  enzyme (2-3 mg SN 
protein), and inhibitor (200 µmol. Ii1 ) .  The reaction mixture was preincubated for 3 min 
at 37 ° C  before starting reaction by addition of ethanol (20 mmol. �1). Absorbance was 
monitored at 340 nm for at least 3 min. 
2The NAD: inhibitor ratio. 
3Values are the means ± SEM of 3 determinations. Values bearing different superscript 
letters (a-c) between rows are significantly different (PS 0. 05). Values bearing 
different superscript letter (w-z) between columns are significantly different (PS 0. 05) . 
4Values in parenthesis indicate percent inhibition with reference to the control. 
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TABLE 4 . 3 
Effect of carnitine and related molecules on ADH 
activity• 
Additions ADH Acti vi tt Inhibition 
[ 200 µmol. L-1 ] (nmoles NADH. min· . mg·1 ) (%) 
None 2. 47 ± 0. 02• 0 
L-Carnitine 2. 24 ± O .  Olb 9. 3 
DL-Carnitine 3. 39 ± o. 02• 0 
Choline 2. 31 ± 0. 01• 6. 5 
Choline (pH 7. 0) 2. 31 ± 0. 03• 6. 5 
Acetyl-L-Carnitine 1. 92 ± O .  O lb 22. 3 
r-Butyrobetaine 2. 39 ± o. 02• 3. 2 
�-OH-Butyrate 2. 54 ± o. 02• 0 
L-Lysine 2. 54 ± 0. 03• 0 
r-Aminobutyrate 2. 47 ± o. 02• 0 
1Conditions: 3 mL of reaction mixture contained sodium 
pyrophosphate buffer (55 mmol. L-1) ,  pH 7. 4, NAD (100 
µmol. L-1 ) , reduced glutathione ( 1. 1 mol. L-1 ) , enzyme 
(2-3 mg SN protein) and inhibitor (200 µmol. �1 ) .  The 
reaction mixture was preincubated for 3 min at 37 ° C  
before starting reaction by addition of ethanol (20 
mmol. L-1) .  Absorbance was monitored at 340 nm for 
at least 3 min. 
2Values are the means ± SEM of 3 determinations. 
Values bearing different superscript letters 
between rows are significantly different (PS 0. 05) 
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TABLE 4 . 4  
Effects of acetyl derivatives on ADB activity1 
Additions ADH Activity2 Inhibition 
( 2 00 µmol. L-1 ] ( nmoles NADH. min-1 • mg-1 ) (%) 
NS 3.  3 3  ± 0. 02•  0 
L-Carnitine 3. 2 1  ± 0. 0 3• 3. 9 6  
Choline 3. 1 6  ± 0. 0 1• 5. 2 5  
Acetylcarnitine 2. 3 7  ± 0. 02b 28. 9 5  
Acetylcholine 2. 98  ± 0. 02b 10. 5 3  
Amonium Acetate 3. 07 ± 0. 0 1• 7. 9 2  
Na-Acetate 3 . 15 ± 0. 02•  5. 2 8  
Acetyl-Co A 2 . 9 8 ± 0. 0 3b 10. 5 3  
•conditions: 3 mL of reaction mixture contained sodium 
pyrophosphate buffer (55mmol. L-1 ) , pH 7. 4 ,  NAO ( 100  
µmol. L-1 ) , reduced glutathion ( 1. 1 mol. L-1 ) , enzyme 
( 2 - 3  mg SN protein), and inhibitor ( 2 00  µmol. L-1 ). 
The reaction mixture was preincubated for 3 min at 3 7  °C  
before starting reaction by addition of ethanol ( 2 o mmol. L-1 ) • 
Absorbance was monitored at 340 nm for at least 3 min. 
2Values are the means ± SEM of 3 determinations. 
Values bearing different superscript letters between rows are 
significantly different (P� 0. 0 5 )  
..... 
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TABLE 4 . 5  
Effect of carnitine and acetylcarnitine on ethanol 
oxidation hy rat liver microsomes (MEOS ) 1 
Ethanol oxidation2 Additions 
( 200 µmol. L-1 ] (mmol. L-1 • h-1 • g·1 microsomal protein) 
None 
L-Carnitine 
L-Acetylcarnitine 
30. 55 ± 0. 98 
3 1 . 68 ± 1 . 14 
31. 84 ± 1. 50 
1Condisions: 3 mL of reaction mixture contained sodium 
potassium phosphate buffer ( 100 mmol. L-1 ) , pH 7. 4, 
MgCl2 ( 5. 0 mmol . L-
1 ) , disodium-EDTA ( 1 mmol . L-1 ) , NADPH 
+ H+ (1. 0 mmol. L-1 ) ,  enzyme (8-10 mg microsomal 
protein), and ethanol (10 mmol. L-1 ) . Reaction mixture 
was incubated for 120 min. at 37 °C in methods. 
2Values are the means ± SEM of triplicate from 3 
different rats. 
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TABLE 4.6  
Inhibition of ADR activity at different concentrations of NAD and L-acetylcarnitine1 
Inhibitor 
25 50 
None 1. 39 1. 93 
L-Acetyl-
carnitine 0. 67 1. 61 
[ 100 µmol. L-1 ] (51. 8)3 (16. 5) 
L-Acetyl-
carnitine 0. 46 1. 12 
[ 200 µmol. L-1 ] (64. 7) (41. 9) 
NAD Concentration ( µmol. L-1 ) 
100 200 400 1000 
ADH Activity ( nmo les NADH. min·1 • mg-1 ) 2 
2. 93 4. 32 4. 77 5. 10 
2. 45 4. 23 4. 77 5. 10 
(16. 3) (2 . 1) (0) (0) 
1. 93 2. 94 4. 00 5. 10 
(34. 1) (31. 9) (16. 1) (0) 
2000 
5. 49 
5. 49 
(0) 
5. 49 
(0) 
1Conditions: 3 mL of reaction mixture contained sodium pyrophosphate buffer (55mmol. L'1 ) ,  
pH 7. 4, NAD (25-2000 µmol. L-1 ) ,  reduced glutathione (1. 1 mol. L-1 ) ,  enzyme (2-3 mg SN 
protein), and inhibitor (100 and 200 µmol. L'1 ) .  The reaction mixture was preincubated for 
3 min at 37 ° C  before starting reaction by addition of ethanol (20 mmol. L'1 ) .  Absorbance 
was monitored at 340 nm for at least 3 min. 
2Values are the means of 2 determinations. 
3Values in parenthesis indicate percent inhibition with reference to the control. 
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than at higher concentrations of NAO+. At a given 
concentration of NAD+, higher concentration (200 µmol. L-1) of 
acetylcarnitine was proportionally more inhibitory than 
lower concentration (100 µmol. �1). The plot of reaction 
velocity and the concentration of NAD (co-substrate) 
resulted in 3 separate hyperbolic curves which obeyed 
classical Michaelis-Menten kinetics (Figure 4. 1). A 
Lineweaver-Burk plot of this data (Figure 4. 2) produced a 
definite shift in the Km without affecting Vmax which is the 
characteristic of competitive inhibition (Table 4. 7). The 
Ki at 100 µmol. �1 and 200 µmol. �1 of acetylcarnitine were 
184. 5 and 135. 1 µmol. �1, respectively. 
In order to access the site of acetylcarnitine 
interaction, NAD+ and acetylcarnitine were preincubated with 
ADH and reaction velocity was measured (Table 4. 8). When 
enzyme was preincubated with acetylcarnitine alone or with 
acetylcarnitine plus NAD+, the inhibition was essentially 
identical, however, when ADH was preincubated with NAD+ 
first the inhibition by acetylcarnitine was decreased . This 
suggested that interactions were at the level of enzyme and 
not NAO. A more direct assessment was made by studying the 
binding ( 1-uC ] -acetylcarnitine to ADH at different ratio of 
NAD: ( 1-14C ] -acetylcarnitine (Table 4. 9). The binding of [ l-
14C ] -acetylcarnitine to ADH was decreased as the ratio of 
NAD: acetylcarnitine was increased. 
The effect of carnitine and acetylcarnitine on the 
t,. 
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TABLE 4 . 7  
Kinetic paraaeters for ADH activity at varying 
concentrations of acetylcarnitine1 
Km 
Additions (µmol . L-1 ) 
None 87 . 64 
Acetyl-L-Carnitine 113 . 02 
( 100 µmol . L-1 ) 
Acetyl-L-Carnitine 217 . 00 
( 200 µmol . L-1 ) 
Vmax 
(µmol . L-1 ) 
5 . 71 
5 . 71 
5 . 71 
Ki 
(µmol . L-1) 
184 . 52 
135 . 09 
1Kinetic parameters were calculated from the values 
in Table 4 . 5 using computer program (Enzfitter) . 
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TABLE 4 . 8  
Znhibition of ADR activity by carnitine, choline , acetylcarnitine, and 
acetylcholine under different experiaental condition 
Inhibitor: NAO Cone. 
[ 2 00: 100 µmol. L-1 ] 
None 
L-Carnitine 
L-Acetylcarnitine 
Choline 
L-Acetylcholine 
Experimental Condition1 
A B 
AOH Activity (nmoles NAOH. min. ·1. mg·1 ) 2 
2. 67 3. 33 
2 . 4 1 3. 20 
( 9 . 8 3 ) 3 (3. 96) 
1. 93 2. 37 
(27. 87) (28. 95) 
2 . 59 ' 3. 16 
(3. 29) (5. 25) 
2. 23 2. 98 
(16. 71) (10. 53) 
C 
2. 67 
2. 63 
( 1 . 64 )  
2. 19 
(18. 05) 
2. 63 
( 1 . 64 )  
2 . 4 1 
(9. 83) 
1Experimental Conditions were as described in table 4 except the following 
A: NAO + inhibitor preincubated for 3 min. prior to ethanol addition 
B: Inhibitor preincubated for 3 min. prior to NAO + ethanol addition 
C: NAO preincubated for J · min. prior to inhibitor + ethanol addition 
2Values are the means of 2 determinations. 
3values in parenthesis indicate percent inhibition with reference to the 
control. 
CD 
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TABLE 4.9 
Binding of (1-"c] -acetylcarnitine to horse alcohol dehydrogenase at 
different ratio of [HAD] : [1-14C] -acetylcarnitine] 1,2 
NAD: [ l-14C]  [ 14C]  DPM/mg Enzyme 
Acety lcarni tine·1 protein % Binding 
0 5051  ± 2 5 2• 5 . 1  ± 0 .  2 3 • 
0 . 5  3 8 4 5  ± 2 4 0b 3 .  9 ± 0 .  2 3b 
1 3499 ± 214c 3. 5 ± 0 . 17c 
2 17 72  ± 102d 1 .  7 ± o. 05d 
1Conditions: 0 . 5  mL of reaction mixture contained sodium pyrophosphate buffer 
( 55  mmol. L-1 ) , pH 7. 4, NAO ( 0-2 nmol. L-1 ) , reduced glutathione ( 1 .  1 mmol. L-1 ) , 
[ 1-14C] -Acetylcarnitine ( 1  nmol. L-1 ) ,  and horse ADH ( 0 . 17 µmo1. L-1 or mg 
protein). Reaction mixture was incubated for 5 min. at 3 7  °c , filtered through 
millipore filter by centrifugation, and counted 14C in the filter. 
2The values are means ± SEM of 3 determinations. 
Values bearing different superscript letters between rows are significantly 
different (PS 0 . 0 5 )  
GO • 
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activity of ADH derived from different species is shown in 
Table 4. 10. Neither carnitine nor acetylcarnitine inhibited 
the yeast ADH activity. However, the activities of ADH from 
horse, rat, guinea pig, mouse and broilers were 
significantly inhibited by acetylcarnitine. 
DISCUSSION 
The analysis of the products of ethanol oxidation by 
hepatocytes (Table 3. 5) revealed 80% inhibition of 
acetaldehyde formation in presence of acetylcarnitine 
suggesting that the site of inhibition must be at the 
enzymatic level. since ADH is the main enzyme of ethanol 
oxidation, it was considered to be the target enzyme for 
studying the effect of carnitine, acetylcarnitine, and 
related compounds. The results showed that acetylcarnitine 
inhibited ADH only when the ratio of NAD: acetylcarnitine was 
low. The inhibition was minimum (7%) at the ratio of 1: 1 
and maximum (45%) at ratio of 1: 8 (Table 4. 2). When this 
ratio was higher than 1: 1, there was no effect of 
acetylcarnitine on ADH (Table 4. 1). On the other hand, at 
any ratio of NAD: carnitine, thheinhibition of ADH was no 
more than 10%. In previous studies (Mynatt and Sachan 1992) 
also, carnitine produced little or no inhibition of ADH. 
The specificity of ADH inhibition by acetylcarnitine was 
determined using structurally related compounds e. g. choline 
and acetylcholine or carnitine precursors namely, r-
TABLE 4 . 10 
Inhibition of ADH from different species by carnitine and acetylcarnitine1 
Species 
Yeast3 
Horse3 
Rat4 
Guinea Pig4 
Mouse4 
Broilers4 
None 
3 6  . 18 ± 0 . 1  • 
0 . 5 3 ± 0 . 0 1• 
3 .  3 3 ± 0 .  2•  
7 .  3 3  ± 0 .  5• 
6 . 4 9 ± 0 . 0 5• 
4 . 0 6 ± 0 . 2 • 
Inhibitor 
L-Carnitine L-Acetylcarnitine 
ADH Activity (nmoles NADH . min-1 • mg-1 ) 2 
3 6 . 18 ± 0 . 2• ( 0 ) 5 
0 . 4 8 ± 0 . 01• ( 9 . 2 )  
3 . 2 0 ± 0 . 2 • ( 3 . 3 ) 
6 . 5 8 ± 0 . 4· ( 8 . 0 ) 
6 .  02 ± 0 .  1 • ( 7 .  3 )  
3 . 8 5 ± 0 . 2• ( 5 . 2 ) 
3 6 • 18 ± 0 • 1 • ( 0 )  
0 . 3 8 ± O . O lb ( 2 7 . 3 ) 
2 . 3 6 ± O . lb ( 2 7 . 9 ) 
5 . 3 7 ± 0 . 4b ( 2 6 . 8 ) 
5 . 03 ± 0 . 2 b ( 2 2 . 5 ) 
3 . 0 1 ± 0 . 3 b ( 1 5 . 3 ) 
1Conditions: 3 mL of reaction mixture contained sodium pyrophosphate buffer 
( 5 5 mmol . L-1 ) ,  pH 7 . 4 ,  NAO ( 1 0 0  µmol . L-1 ) ,  reduced glutathione ( 1 . 1 mol . L-1 ) ,  
enzyme ( 2 -3 mg SN protein), and inhibitor ( 2 0 0 µmol . L-1 ) .  The reaction mixture was 
preincubated for 3 min at 3 7  °C  before starting reaction by addition of ethanol . 
Absorbance was monitored at 3 4 0  nm for at least 3 min . 
2Values are the means ± SEM of triplicate determinations . Values bearing different 
superscript letters between columns are significantly different (P� 0 . 0 5 )  
3The ADH was purchased from ·the Sigma Chemical co . 
4The ADH was prepared by differential centrifugation and 100 , 0 00 x g supernatant was 
used . 
5values in parenthesis indicate percent inhibition with reference to the control . CD °' 
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butyrobetaine and lysine . Among these compounds , only 
choline , acetylcholine , and butyrobetaine inhibited ADH 
approximately 5% , 14% , and 3%, respectively (Table 4. 2-4. 3) . 
Because of relatively high degree of inhibition by 
acetylcarnitine and acetylcholine compare to carnitine and 
choline , it was necessary to examine effect of acetyl 
moiety . Acetyl group by itself was not able to inhibit ADH 
any more than choline or carnitine , however , acetyl-CoA was 
as effective as acetylcholine, both of which at equimolar 
concentration produced only about 30% of the inhibition 
caused by acetylcarnitine (Table 4 . 4 ) . Therefore , it is 
concluded that the inhibition of ADH by acetylcarnitine is 
specific and can not be matched by the related compounds we 
studied . These result provide explanation for the lack of 
significant (10%) inhibition by choline (Sachan and Berger 
1993) and the requirement of a pretreatment period with 
carnitine for its inhibition of ethanol metabolism in the 
intact rat (Sachan 1992) . In the intact system , it would be 
difficult to maintain a low ratio of NAD: acetylcarnitine 
because NAD+ is being constantly regenerated and 
acetylcarnitine is being excreted in urine . However , the 
picture may be quite different in the chronic alcoholic 
condition . 
There are a large number of molecules which have some 
degree of inhibitory effect on ADH (Table AS . l) . Among 
these Pyrazol and its 4-substituted derivatives are most 
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potent and widely studied compound with regard to ADH 
inhibition (Goldberg and Rydberg 1969 , Oanielesson et al . 
1992 ) . The inhibition varies with the isozyme involved e . g . 
rat ADH 3 has a Ki = 0 . 4  µM , ADH 1 ki = 0 . 56 µM but AOH 2 is 
insensitive to pyrazol (Julia et al . 198 6 ) . Pyrazol and its 
analogues are competitive inhibitors of ADH (Goldberg and 
Rydberg 19 69 ) which is brought about by formation of an 
extremely tight ADH-NAD+ and pyrazol ternary complex 
(Khalifah and Sutherland 1979 ) . The precise mode of binding 
of pyrazoles has not been elucidated . However , it is 
_proposed that heterocyclic ring of pyrazole forms a bridge 
through its two nitrogen atoms and the catalytic z inc atom 
and C-4 of the nicotinamide moiety of NAO (Branden et al . 
197 5 ) . The mechanism of acetylcarnitine inhibition may be 
similar to that of pyrazole since it does have quaternary 
nitrogen . 
Inhibitor molecules bind to enzyme protein either . at the 
coenzyme binding site or at the substrate binding site . 
Three main coenzyme binding sites where inhibitors are known 
to bind are 1 )  the adenosine binding cleft for aromatic 
molecules , 2 )  the anion binding site where the pyrophosphate 
group of the coenzyme binds , and 3 )  the nicotinamide binding 
region (Branden et al . 1975 ) . Acetylcarnitine appears to 
bind to AOH at the site of NAO binding since NAO inhibited 
acetylcarnitine binding to AOH in a dose dependent manner . 
When the ratio of NAD : acetylcarnitine was increased from o 
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to 2, binding of ( 1-14c-acetylcarnitine to ADH decreased 67% 
(Table 4. 10). The affinity of ADH for binding is greater 
for NAD than acetylcarnitine as indicated by preincubation 
experiments shown in Table 4. 9. However, these experiments 
do not inhibitory rule out the possibility of alteration of 
NAD configuration by acetylcarnitine. 
Acetylcarnitine-NAD+ interactions inhibited ADH 
preparations from broiler chicken, guinea pig, horse, mouse, 
rat but not the enzyme from yeast (Table 4. 11). The 
specificity may be related to different isozymes of the 
species (Julia et al. 1987). The ADH is not a single enzyme 
but a system consisting of many isozymes which are species 
specific to a certain degree. Yeast and mammalian ADH 
differ in substrate specificity and rate of catalytic 
activity (Branden et al. 1975). Human and rodent ADH exists 
as a heterogeneous group of isoenzymes that can be placed 
into three categories based upon structural and functional 
distinctions (Strydom and Vallee 1982). There are clear 
analogies between human ADH classes and rat ADH isoenzymes. 
There is approximately 82% sequence homology among subunits 
of human and rat liver ADH (Julia et al. 1987). The kinetic 
and molecular properties of rat ADH 3 are similar to those 
of human class I isoenzymes. It is well known that ethanol 
is the substrate for classical human class I ADH (Li 1977) 
and rat ADH 3 (Julia et al. 1987) isoenzyme. Both human 
class I and rat ADH 3 are mainly localized in liver and rat 
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enzyme exhibits a Km of 1. 4 mmol. L-1 for ethanol and it is 
strongly inhibited by pyrazole, ki = o. 4 µmol. L-1• 
This data provides molecular explanation for carnitine­
mediated attenuation of ethanol metabolism in the intact rat 
(Sachan and Berger 1987, Mynatt and Sachan 1992), mouse 
(Sachan 1992) and broiler chicken (Smith et al. 1993). 
These similarities and differences among species must be 
born in mind in extrapolation of rat data to humans. 
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APPBBDICES 
APPENDIX 1 
BEPATOCYTE PREPARATION 
A.  Preparation of solutions for perfusion 
Table A 1 . 1 . 
compos ition of buffers used for collagenase perfus ion 
Chemicals Ca+ +-free Collagenase suspension Krebs-
95  
(g) perfusion buffer (L) buffer (L) Henseleit 
buffer (L) buffer(L) 
NaCl 8 . 3  0 . 39 0 . 4  9 
KCl 0 . 5 0 . 05 0 . 04 0 . 46 
CaC12 0 . 529 0 . 0136 0 . 37 
MgC12 • 6H20 0 . 013 
KH2P04 0 . 05 0 . 21 
MgS04 0 . 38 
Na2S04 0 . 01 
NaHC03 2 . 73 
HEPES 2 . 4 2 . 4  0 . 72 
TES 0 . 69 
Tricine 0 . 65 
1 M NaOH 5 . 5  6 . 6  5 . 25 
Collagenase 0 . 05 
pH 7 . 4 7 . 6  7 . 6  7 . 4 
B .  Preparation of apparatus 
We used the perfusion apparatus similar to that described 
by Seglen (Seglen 197 6) and shown in Figure A 1 . 1 .  
1 .  It ' s  most important unit is the water-jacketed 
coiled tube (1), which maintains the perfusate 
temperature at 37 °C  (2 x 4 mm glass tube in 22 to 24 
coil ; coil diameter 30 mm ; coil length 100 mm) . 
2 .  A combined filter unit and bubble trap (2) is made 
of a short piece of silicone rubber tubing with a 
rubber stopper in each end ; stainless-steel 
cannulas are used to pierce the stopper . A cotton plug 
+-{D 
FIGURE A · 1 . 1  Experimental apparatus for liver perfusion 
(Seglen 1976) 
'° 
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is used as a filter ; the cotton is carefully packed at 
the portal, end of the fluid-filled filter unit, taking 
care to avoid the trapping of bubbles within the cotton. 
3. From the other end of the coiled tube a long 
stretch (90 Cm) of 2 x 4 mm silicone rubber tubing 
leads through the pump (3) to the buffer reservoir. 
4. The coiled tube is fixed with a clamp onto a 
flexible lamp holder. The whole coiled tube­
filter-cannula assembly can thus be moved freely in all 
directions, which facilitates exact positioning of the 
portal cannula and easy transfer of the cannulated liver 
from the body to the liver dish. 
5. The latter is a flat glass bottle (diameter 80 mm) 
with a conical outlet (4) ; the isolated liver is 
placed on a nylon net in the bottom of the dish. 
6. When ca+ +-buffer is recirculated before perfusion, 
the oxygenation (5) is provided to sufficient 
surface area for complete oxygenation of the 
perfusate. 
c .  surgical procedure and perfusion 
1. The rat was anesthetized by Metofane (Pitman-Moore, Inc. 
Mundelein, IL) in jar placed a hood , it was carefully 
transferred to the operating tray. 
2. The rat was placed on its back on the operating tray 
with its neck stright. The abdomen was opened by a v-
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shaped incision, begining at lower abdomen and extending 
to the back near last left ribs. The intestines were 
displaced to the left side of the abdominal cavity (right 
of operator) so that portal vein and posterior vena carva 
were in right. 
3. A loose ligature was placed around the portal vein 
at about 1 em poster to entry point in liver (Fig. A 
1. 1). The portal cannula was then placed adjacent to the 
portal vein. 
4. The perfusate flow (ca+ +-free perfusion buffer) is 
started at a rate of 30 mL per min. The oxygenator 
cylinder is used as a reservoir for the perfusion buffer 
(about 500 mL), which was maintained at 37 °C  and 
saturated with oxygen. 
5. A deep cut was made in the posterior vena cava and using 
a fine scissors a small (hafeway through wall) cut was 
rapidly made in the petal vein a few mm inferior . to 
ligature (Fig. A 1. 1: upper arrow). 
6. The portal cannula was rapidly inserted into the vein 
through the cut and pushed up towards lower so that it 
lies about portal 2-4 mm inside the ligature. The 
ligature was securely tied and secured in place with an 
extra knot. 
7. The perfusate flow was increased to 50 mL per 
minute. The first 2-3 minutes of preperfusion was 
allowed while the liver remained intact in situ. 
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8. While preperfusion is continued, the liver was removed 
from the carcass by cutting all attachments including the 
vascular and biliary supply distal to the ligature (one 
cut), both ends of the vena cava as close to the liver as 
possible, and the thin, clear ligaments to the intestines 
and the abdominal wall. Care was exercised to avoid 
twisting of the hepatic lobes, cutting into the liver 
tissue, and rupture of the liver capsule due to 
stretching of the ligaments. 
9. The liver is transferred to the liver perfusion dish ( 
temporarily placed on top of a 250 mL beaker) and laid 
flat in a normal position similar to them in situ 
position. A good perfusion of liver should allow 
rapid perfusate afflux with no swelling, and the 
whole liver should have a uniform, light-tan color. 
10. When 500 mL of the ca+ +-free perfusion buffer in the 
oxygenator-reservoir has been used about 10 min, -the flow 
pump was momentarily stopped, and reservoir was changed 
from ca+ +-free buffer to collagenase buffer. 
11. The perfusate flow was immediately reswitched at its 
maximal rate (50 mL. min), and the liver dish was placed 
on top of the collagenase buffer beaker. 
12. The liver is perfused with recirculating 
collagenase buffer 50 mL. min for 7-10 minutes ; during 
this time it swells to more than twice its original 
size. 
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13. The liver is then transferred to a watch glass 
containing 5 mL of KHB with 2. 5% BSA. The liver is 
held up with forceps (portal region) and gently shaken, 
the cells are liberated from the liver connective and 
vascular stroma by careful raking with a stainless­
steel fork. 
D .  Cell collection and viability test 
1. The cell suspension was distributed in a 10 mL KHB with 
2. 5% BSA and centrifuged in a Beckman TJ-6R tabletop 
centrifuge at 50 x g for 3 min at 25 °C. 
2. The supernatant and lose pellet was discared and heavy 
cells fluid was resuspened in 10 mL of KHB with 2. 5% BSA 
and centrifuged as above. 
3. The final packaged cells were suspened in KHB with 2. 5% 
BSA and kept at room temperature until the experiment. 
4. Cell suspension was diluted 1: 10 and 100 µL of it was 
treated with 0. 6% trypan blue (1: 1). The cells .were 
counted in a hemacytometer, 4 outer squares, using an 
Olympus T041 microscope. Cell numbers was calculated as 
follow: Cells/mL = # of counted cell x DF / 4 and % of 
viability was determined (should be upper 90 %). 
References : 
1. Seglen, P. o .  (1976) Preparation of isolated rat 
liver cells. Meth. in Cell Ciol. 13: 29-83. 
2. Horne, D. W. , Briggs, w .  T. & Wagner, c .  (1976) A 
functional, active transport system for methotrexate in 
freshly isolated hepatocytes. Biochemical and 
Biophysical research communications 68: 70-76. 
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Acetylcarnitine was determined spectrophotometrically by 
the method of Pearson et al. (Pearson et al. 1974) . 
Principle 
CAT 
(1) Acetylcarnitine + CoASH<=====> carnitine + Ac-CoA 
citrate 
(2) Ac-CoA + Oxaloacetate----------> Citrate + CoASH 
syntbue 
MDH 
(3) Malate + NAD+ <======> Oxaloacetate + NADH + H+ 
The acetyl-CoA formed in reaction (1) reacts with 
oxaloacetate in the presence of citrate synthase to give 
citrate ( eqn. (2) ] ;  CoASH is regenerated. The consumption of 
oxaloacetate leads to disturbance of the equilibrium of the 
malate dehydrogenase (MDH) reaction (3) with consequent 
reduction of NAD. The increase in the NADH concentration, as 
meassured by the extinction at 340 nm, is the unit of 
measurement. 
Equipment 
Spectrophotometer for measurements at 340 nm. 
Reagents 
1. 1 M Potassium malate: Dissolve 13. 4 g L-malic acid in 
water , adjust to pH 7. 5 with 5 N KOH , and make vol. to 
100 mL with distilled water. 
2. 10 mM P-Nicotinamide-adenine dinucleotide: Dissolve 23. 1 
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mg NAO in approx. 1 mL distilled water, add 0. 045 mL lN 
KOH, and dilute to 3 mL with distilled water. 
3. 10 mM Coenzyme A: Dissolve 10 mg CoA in 1 mL distilled 
water. 
4. Malate dehydrogenase, MOH (1 mg protein. mI:1 ) :  Dilute 
stock suspension to get desired concnetration with 3. 2 M 
ammoniumsulphate solution (pH=6. 0) 
5. citrate synthase, cs (1 mg protein. mI:1 ) :  Dilute stock 
suspension to ge desired concentration with 3. 2 M 
ammonium sulphate solu�ion (pH=6. 0). 
6. 1 M Tris buffer (pH 7. 8): Dissolve 12. 1 g tris in 65 mL 
1 N HCl, and make up to 100 mL with distilled water. 
7. 50 mM Ethylenediaminetetra-acetate, EDTA: Dissolve 0. 46 
g EDTA-Na2H2. 2H20 in 20 mL distilled water, adjust pH to 
8 with 1 N KOH, and make up to 25 mL with water. 
8. carnitine acetyltransferase, CAT (l mg protein. mL-1 ) :  
Dissolve 1 mL suspention in 4 mL potassium phosphate 
buffer. 
9. 0. 5 M Phosphate buffer (pH 7. 5): Dissolve 6. 8 g KH2P04 in 
approx. 70 ml of water, adjust to pH 7. 5 with approx. 
2. 2 mL 5 N KOH, and make up to 100 mL with distilled 
water. 
10. 50 mM Perchloric acid: Dilute 4. 2 mL 70% HC104 to 100 mL 
with distilled water. 
11. 30 mM Acetylcarnitine: 
12. 30 mM Acetyl-CoA: 
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Procedure 
A standard curve was prepared by adding o ,  10, 20, 40, 
60, 80 and 100 µl (Table A 2. 1) of acetylcarnitine standard 
(30 mM) to tubes containing 100 µl 10% BSA, 300 µl of 3. 0 M 
HC104 and double distilled water to a total volume of 1. 65 
mL. The tubes were vortexed vigorously for 30 sec and 
allowed to sit in an ice water bath for 5 min, vortexed 
again and centrifuged for 10 min at 1500 x g at 2 ° C. 
1. 0 mL of the supernatant was removed and added to 
another conical tube on ice. 200 µl of 3 M  KHC03 was added, 
vortexed and allowed to sit for 15 min, then centrifuged for 
10 min at 1500 x g at 2 °C. The supernatant was then poured 
off into another tube on ice. 
A 100 µl aliquot of the neutralized standard or samples 
(cell supernatant) were added to 1. 86 mL of reaction mixture 
(1) in a 3 mL polystyrene disposable cuvette (Baxter 
Scientific Products, Atlanta, GA) and mixed by inversion and 
read extinction (Ei). MDH suspention (2) was pipetted into 
the cuvette, mixed, waited until equilibrium was reached, 
and read extinction ( :Ei ) • cs suspension (3) was 
added, mixed, waited until reaction stoped, and read 
extinction (E3 ) .  Acetyl-CoA in the sample was reacted. CAT 
solution (4) was mixed, waited until reaction stoped, and 
read extinction (E3 ) .  Acetylcarnitine was reacted in this 
reaction (5-15 min). 
@E1 = E2 - E1 @:Ei = E3 - Ei @E3 = E4 - E3 
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Table A 2 . 1 
Reaction mixture and summary of procedure 
Reagent volume (ml) Final Con. in 
assay mixture (mM) 
(1) 1 M Tris buffer 0. 20 100 
L-Malate solution 0. 02 10 
EOTA solution 0. 05 1. 25 
NAO solution 0. 10 0. 5 
CoA solution 0. 025 0. 125 
Water 1. 465 Vt =l. 96 
(2) MOH suspention 0. 01 5 µ.g. mL
-1 = 5. 5 U. mL·1 
( 3 )  cs suspension 0. 02 10 µ.g. mL·
1 = 0. 7 U. mL-1 
(4) CAT solution 0. 01 5 µ.g. mL·
1 = 0. 6 U. mL·1 
3 0  
No . µL 
1B 0 
2RS1 10 
3RS2 20 
4RS3 4 0  
5RS4 60 
6RS5 80 
7RS6 100 
8Sl 
mM Ac-CNE 
µmol ( µM) 
0 0 
0 . 3  9 . 1 
0 . 6 18 . 2  
1 . 2  36 . 4  
1 . 8  54 . 5  
2 . 4  7 2 . 7 
3 . 0  9 0 . 9  
Table A 2 . 2 
Example of an assay 
3 0mM Ac-CoA o .w .  
(µL) 
µL µmol ( µM) 
0 0 0 1250 
10 0 . 3  9 . 1 123 0 
20 0 . 6  18 . 2  1210 
4 0  1 . 2 36 . 4  117 0 
60 1 . 8  54 . 5  113 0 
80 2 . 4  7 2 . 7 109 0 
100 3 . 0  90 . 9  1050 
100 -1000  µL 
V1 = 1 .  65 
RS = Refereced Standared, S = Sample 
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3 M 3 M 
10%BSA HC104 KHC03 
(µL) (µL) ( µL) 
100 3 0 0  200 
10 0 3 00 200 
10 0 3 0 0  200 
100 3 0 0  20 0 
100 3 00 200 
100 3 00 20 0 
10 0 3 00 200 
100 3 0 0  200 
Calculations 
Extinction coefficient of NADH : 
c = 6. 22 cm2 • µmole.1 at 340 nm 
#1. Acetyl-CoA : 
C = 
6. 22 
Where Q = 
x 2 ( µmole. cuvette·1 contents ] 
/32 + 2/3 
/3 + 1 
and (3 = 
#2. Acetylcarnitine + Acetyl-CoA : 
C = 
6. 22 
Where a = 
x 2 (µmole. cuvette contents·• ] 
(/3') 2 + 2/3') 
(3' + 1 
and (3' = 
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The value for aceylcarnitine is found from the difference 
between equations #2 and #1. If the sample contains · no 
acetyl-CoA , @E2 = o ,  and the calculation is simplified. 
Normal Values : Tissues of rats 377 ± 62 n mole per g of 
frozen heart muscle and 41 ± 9 n mole per g of frozen liver. 
Reference : 
1. Pearson , D. J. , Tubbs , P. K. & Chase , J. F. A. 
(1759) Canitine and acylcarnitines. In : Methods 
of enzymatic analysis , Vol. 3 (Bergmers , H. v . , 
ed. pp. 1758-1818 , Verlay chemie Intern , Deerfield 
Beach , Fla. 
APPENDIX 3 
ACETATE DETERMINATION 
Acetate was determined by a enzymetic determination by 
using acetyl-CoA synthetase as described by Guynn and Veech 
(Mellanby & williamson 1974), with some modifications. The 
acetate concentration was determinated as the difference in 
the initial and final readings by using a potassium acetate 
standard curve. 
Principle 
The method is based upon the enzyme sequence : 
Acetate- + ATp4- + CoA = AMP2- + pp4- + acetyl-CoA + H+ 
Acetyl-CoA + oxaloacetate2- = citrate3- CoA + H+ 
Malate2- + NAD+ . = oxaloacetate2- + NADH + H+ 
Net : Acetate- + ATp4- + malate2- + NAD+ = AMP2-
+ pp4- + ci trate3- + 3H+ + NADH 
The assay depends upon the conversion of acetate to 
acetyl-CoA and the measurement of the acetyl-CoA by a 
coupled system of malate dehydrogenase and citrate synthase. 
Equipment 
Spectrophotometer for measurements at 340 nm. 
Reagents 
a) Stored at 0-4 °C  
1. 0.2 M Tri-HCl, pH 8. 0 containing KCl, 0.1 M :  
2. 0. 1 M Magnesium chloride : 
3. 5.0 mM NADH, in 0. 3% (w/v) KHC03 , Stable for 5-7 
days : 
4. 1.2 M Perchloric acid : 
b) Stored below -15 °C 
5. 27 mM Adenosine 5'-triphosphate, Tris, Potassium or 
sodium salt: 
6. 24 mM NAO+, free acid: 
7. 0. 1 M Malate, Potassium salt: 
8. 1. 2 mM Coenzyme A, free acid, containing 
3. 0 mM of mercaptoethanol, prepare fresh good for 1 
week 
9. Bovine serum albumin, 100 mg. mL-1 : 
10. Acetyl-CoA synthtase: 
Procedure 
Preparation of reagent cocktail : 
All reagents were prepared in deionized water and 
neutralized when necessary with either HCl or KOH. 
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A cocktail was prepared containing 90 mmol Tris-HCl. L-1 
(pHS) , 2. 7 mmol ATP. L-1 , 0. 075 mmol NADH. L-1 , 0. 6 NAO mmol. L-1, 
12 mmol coenzyme A. L-1 , o. 6 mmol malate. L-1 , 4. 5 mmol 
magnesium chloride. L-1 , o. 3 mmol mercaptoethanol. L·1 , 45 mmol 
potassium chloride. L·1 , 12 u. mL·1 malate dehydrogenase, 0. 5 
u. mL·1 citrate synthase, and 50 mg ddialized BSA. mL-1 ( Table A 
3 .  1 )  • 
A standard curve was prepared by adding o, 25, 50, 100, 
150, and 200 µl of 1 mM of potassium acetate standard to 
tubes and made total volume 1 mL. 
1 mL of standard and incubated hepatocyte supernatant 
(SN) was centrifuged at 2ooox g for 10 min at 25 ° C. 
0. 5 mL of SN filtrate was transferred to a cuvette and 1 
ml of the cocktail was added. Each cuvette was mixed by 
inverting and the optical density (OD) was read in a 
spectrophotometer at 340 nm (A1 ) .  
111 
2µL of stock enzyme (36 u. mL-1 ) acetyl-CoA synthetase 
was added to get 0. 075 u. mL·1 , mixed, and allowed to stand 
for 40 min. The OD of the sample was again read at 340 nm 
The acetate concentration was determined as the 
difference in the initial and final readings (Ai- A1 ) by 
using a potassium acetate standard curve. 
Reference : 
1. Guynn, R. w. & Veech, R. L. (1975) Enzymatic 
determination of acetate. In: Methods of enzymology, 
vol. 35 (Lowenstein, J. M. , ed). pp. 302-7. Academic 
press, New York, NY. 
2. Bridges, s. R. , Anderson, J. w. , Deakins, D. A. , 
Dillon, D. W. & Wood, c. L. (1992) Oat bran 
increases serum acetate of hypercholesterolemic men. 
Am. J. Clin. Nutr. 56: 455-9. 
Table A 3.1 
Preparation of A cocktail 
Required con . uL/ 1  mL 
9 0  nunol Tris-HCl . L-1 (pHS ) : 
2 .  7 nunol ATP . L-1 : 
0 .  075  nunol NADH . L-1 : 
0 . 6  nunol NAD . L-1 : 
o . 1 2 nunol coenzyme A .  L-1 : 
0 . 6  nunol malate . L·1 : 
4 . 5  nunol magnesium chloride . L·1 : 
o .  3 nunol mercaptoethanol .  L-1 : 
4 5  nunol potassium chloride . L·1 : 
5 0mg .  mL-1 dialized BSA 
12  U .  mL-1 ma late dehydrogenase . 
0 . 5  U . mL-1 citrate synthase , 
0 . 07 5  U . mL-1 Acetyl coA synthase 
450  
100 
15 
25 
1 2  
60 
50  
1 0 0  
45  
20  
10 
3 
2 
Stok Cone . 
2 0 0  mM 
2 7  mM 
5 mM 
2 4  mM 
10  mM 
0 . 1 M 
0 . 1  M 
0 . 3  mM 
1 M · 
10%  BSA 
1000 U/mL 
1 .  67  U/mL 
3 6  U/mL 
112 
113 
Table A 3 . 2  
Bxaaple of an assay 
w-std Cock Final 
1 mM K-Ac D.W tail AcCoAs Vt con . 
No . ( µ l )  nmole (ml ) (ml ) (µl )  (ml )  ( µM] A1 
lB 0 0 1000 1000 2 0  1 . 5 0 0 
2RS1 25  25  975  1000  20  1 . 50 12 . 2 6 
3RS2 5 0  50  950  1000  20  1 . 50 2 4 . 5 1 
4RS3 100  100  900  1000 2 0  1 . 5 0 4 9 . 02 
5RS4 150  150 850 1000 20 1 . 50 7 3 . 53 
6RS5 2 0 0 2 0 0  800  1000  20  1 . 5 0 9 8 . 0  
7 Sl 500  µL 1000 2 0  1 . 5 0 
APPENDIX 4 
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Principle 
CH3CHO + NAO
+ � =======0) CH3COOH + NADH + H
+ 
Although the equilibrium of the reaction lies in favour 
of acetate and NADH, quantitative oxidation of acetaldehyde 
is possible with the yeast enzyme. Therefore the rate of 
reaction which is proportional to the aldehyde concentration 
over a limited range, is used. 
Equipment 
Spectrophotometer for measurements at 34 0 nm. 
Reagents 
1. 0. 1 M Potassium chloride: Dissolve 74. 5 g KCL in 
distilled water and make up to 1 L. 
2. 1 M Tris buffer pH 8. 0: Dissolve 30 g tris in 150 
mL distilled water, adjust to pH 8. 0 with 4 N HCL 
and dilute to 250 mL with distilled water. 
3. 0. 1 M EDTA: Dissolve 3. 7 g EDTA-Na2H2. 2H20 in 
distilled water and make up to 100 mL. 
4.  0. 1 M Mercaptoethanol: dissolve 0. 78 g 
mercaptoethanol in distilled water and make up to 
100 mL. 
5. 15 mM P-NAD: Dissolve 100 mg NAO in distilled water 
and make up to 10 mL. 
6. NAO-buffer mixture: Immediately before use mix 3 
volumes of solution 1, 6 volumes solution 2, 0. 5 volume 
solution 3, 0. 5 volume solution 4, and 0. 5 volume 
solution 6. 
7. 2 M Acetaldehyde stock solution: Prepare a 10 % 
solution of freshly distilled acetaldehyde in 
distilled water. 
8. 5 U.mL� Aldehyde dehydrogenase: Thaw the frozen 
enzyme solution and dilute accordingly with 
distilled water. 
Procedure 
1. 2 mL of incubation SN was rapidly pipette into a 
cuvette. 
2. 1 mL of NAO-buffer mixture was added, mixed rapidly, 
put on cuvette lid, and read extinction E1 9 
3. 0.025 mL Adehyde dehydrogenase suspension (150 U.3 
mL-1) was added, mixed. 
4. After exactly 10 min, read extinction Ei • 
5. Calculation: @E = E1 - Ei. 
116 
Table A 4 . 1  
Reaction mixture , sUJDll&ry of procedure 
Pipette into cuvettes 
mix. 
Vol. (mL) Con.in assay 
Deproteinized, neutralized 
Sample or Std. 
HAD-Buffer Mixture 
1 M KCl 
1 M Tris buffer 
(pH 8.0) 
0.1 M EDTA 
0.1 M Mercaptoethanol 
15 mM /3-NAD 
Read E1 at 340 nm 
3 p 
6 p 
0.5 p 
0.5 p 
0.5 p 
Add aldehyde dehydrogenase 
2 
1 
Vt = JmL 
94mM 
0.189M 
1.58mM 
0.24mM 
> 50 mU.mL-1 
150 mu. JmL-1 
0. 15 U. JmL-1 
Mix, immediately start a stop watch and read E2 exactly 
10 min. later @E = E2 -E1 is used for · the 
calculations. 
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Table A 4 . 2  
Example of an assay 
w - Std 
NAO-Buffer 
No . 2 mM Acetaldehyde D . W .  Mixture 
{µL) {µmole) {mL) {mL) 
--is 0 0 2 1 
2RS1 50 0 . 1  1 . 95 1 
3RS2 100 0 . 2  1 . 90 1 
4RS3 200 0 . 4  1 . 80 1 
5RS4 300 0 . 6  1 .  70 1 
6RS5 400 0 . 8  1 . 60 1 
7RS6 500 1 1 . 5 1 
Sl up to 2 mL 1 
Reference : 
1 .  Lundquist, F .  {1974) Determination with 
dehydregenase . In: Methods of enzymology, vol 3 
{Lowenstein, J . M . ,  ed) . pp . 1509-1513 . Academic 
press, New York, NY . 
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{µL) 
30 
30 
30 
30 
30 
30 
30 
30 
APPERDIX 5 
ACETOACETATE DETERMINATION 
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Acetoacetate was determinated by the fluorescent 
spectrophotometry method (Mellanby and Williamson 1974). 
The decrease in NADH concentration was measured by the 
decrease in fluroescence as acetoacetate was reduced to 3-
Hydroxybutyrate. 
Principle 
D- (-)-3-Hydroxybutyrate + NAD+ 
Acetoacetate + NADH + H+ 
Reagents 
3-HBDB 
1. 1 M K2HP04 • NaH2P04 (pH 7. 0) : Dissolve 21. 8 g K2HP04 
and 19. o g NaH2P04 2H20 in 200 mL of double 
distilled water adjust pH to 7. 0 as necessary with 
4 M KOH and bring up to 250 mL with double 
distilled water. Store at 4 °C. 
2. 5 mM NADH: Dissolve 3. 5 mg P-NADH-Na2 , Grade III  
from yeast (Sigma, St. Louis, MO) per mL of 
carbonate buffer. Heat to 60 °C  for 15 min and 
store at -20 °C. Make fresh weekly. 
3. 0. 1 M Na2C03 • NaHC03 (pH 10. 6) : Dissolve O .  85 g Na2C03 
and 0. 17 g in 75 mL double distilled water adjust 
pH as necessary with 4 M KOH and bring up to 100 mL 
double distilled water. Store at -20 °c . 
4. 20 mM Tris Buffer ( pH 8. 0): dissolve 0. 24 g 
Tris (Sigma, St. Louis, MO) in 75 mL of double 
distilled water adjust pH to 8. 0 with 1 M HCl add 
200 µL 10% BSA and bring to 100 mL. Store at -20 
o c .  
5. 3-Hydroxybutyrate Dehydrogenase. type I I  from 
Rhodopseudomonas spheroides in 3. 2 M (NH4)2S04 ( 
Sigma, St, Louis, MO). 
6. 1 mM Acetoacetate: Dissolve 11. 5 mg Acetoacetic 
acid- Lithium salt ( Sigma, st. Louis, MO) per mL 
double distilled water. This yields a 110 mM 
solution. Dilute to 1 mM by adding 100 µL to 9. 9 mL 
double distilled water. 
7. 3 M  HCl04: Dilute 25 mL 70% HCl04 to 100 mL with 
double distilled water. Store at 4 °C. 
8. 10% BSA : Dissolve 10 g BSA in 75 mL double 
distilled water bring to 100 mL with double 
distille water. 
9. 3 M  KHC03 : Dissolve 30 g of KHC03 in double 
distilled water and make up to 100 mL. Store at -20 
o c .  
10. Reagent Mixture: Add 10 mL 1 M phosphate buffer and 
100 µL of 5 mM NADH to 90 mL double distilled 
water. Prepare fresh daily. 
Procedure 
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1. A standard curve was prepared by adding o ,  10, 20, 40, 
60, 80 and 100 µL (Fig. A 5. 1) of acetoactate standard to 
tubes containing 100 µL 10% BSA, 300 NL 3 M  HC104 and 
double distilled water to a total volume of 1. 65 mL. 
2. The tubes were vortexed vigorously for 30 sec and 
1 20 
y = - 6.4751 + 43. 1 755x R z:: 0.99 
1 00 
80 
60 
40 
20 
0 ..__.L_�---.-----,----.---r-----,3 
0 2 
Acetoacetate 
( nmo l .  mL )  
FZGURE A s . 1  Acetoacetate standard curve 
12 2 
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allowed to sit in an ice water bath for 5 min vortexed 
again and centrifuged for 10 min at 1500 x g at 2 ° C. 
3. The supernatant was then poured off into another tube on 
ice. 
4. A 100 µL aliquot of the neutralized standard or tissue 
supernatant was added to 1. 9 mL of reaction mixture in a 
4. 5 mL polystyrene Ultra-Vu disposable cuvette (Baxter 
Scientific Products, Atlanta, GA) and mixed by 
inversion. 
5. Baseline fluorescence was determined in a Hitachi F-2000 
Fluorescence Spectrophotometer (Exitation 360 and 
Emission 400 nm) 10 µL of BHBDH was then added. 
6. The cuvettes were mixed by inversion and let sit at room 
temperature for 60 min in the dark. 
7. After 60 min fluorescence was determined again. The 
decrease in fluorescence was proportional to the 
concentration of acetoacetate. 
Calculations 
Fluorescence x 1. slope x 5 = nmoles. mL·1 SN 
Fluorescence x 1. slope . mg liver = nmoles. mg·1 liver 
Fluorescence x 1. slope x 10 = nmoles. mL·1 urine 
Reference : 
1. Mellanby, J. & Williamson, D. (1974) Acetoacetate In: 
Methods of enzymatic analysis (Bergmeyer, H. u .  ed) 
vol. 4. pp. 1840-1843. Verlag Chemie. Intl. Deerfild 
Beach, FL. 
APPENDIX 6 
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3-Hydroxybutyric acid was determined according to the 
procedure of Williamson and Mellanby (1974) adapted for 
spectrophto fluorometer. The concentration of NADH is 
measured by an increase in fluorescence as 3-Hydroxybutyrate 
is oxidized to acetoacetate. 
Reagents 
1. 1 M 2-Amino-2-methyl-l-propanol buffer (pH 10): 
Dissolve 8. 9 g 2-amino-2-methyl-1-propanol (9. 5 mL 
if liquid) in double distilled water, adjust pH to 
10 with 12 M HCl and dilute to 100 mL with double 
distilled water. Store at -20 °C. 
2. 20 mM Tris buffer (pH 8): Dissolve 0. 24 g 
Tris (Sigma, st. Louis, MO) in double distilled 
water adjust pH to 8 with 1 M HCl add 200 µL 10% BSA and 
dilute with distilled water to 100 mL. Store at -20 °C. 
3. 20 M Hydrazine hydrate: (Sigma, St. Louis, MO) 
4. 0. 1 M P-Nicotinamide dinucleotide (Grade III) from 
yeast (Sigma, st. Louis, MO): Dissolve 70 mg NAD in 
1 mL double distilled water. Store at -20 °C. 
5. Lactate dehydrogenase, LOH: Dilute stock LDH, 
Bovine heart Type III  in 2 . 1 M (NH4)2S04 (Sigma, St. 
Louis, MO) with 20 mM Tris buffer. 
6. 1 mM 3-hydroxybutyrate: Dissolve 15. 4 mg DL-3-
hydroxybutyric acid-sodium salt (Sigma, St. Louis, 
MO) per mL double distilled water this yields a 0. 1 
M solution. Dilute to 1 mM by adding 200 µL to 9. 8 
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mL double distilled water. Make fresh daily. 
7. 3 M  Perchloric acid: Dilute 25 mL of 70% HC104 with 
double distilled water to · 100 mL . 
8. 3 M  Potassium hydrogen carbonate: Dissolve 30 g 
KHC03 with double distilled water and make up to 
100 mL. 
9. Reagent mixture: Mix 10 mL buffer (l), 250 µL 
Hydrazine hydrate and 50 µL NAD and bring to 100 mL 
with double distilled water. Make fresh daily. 
Procedure 
1. A standard curve was prepared by adding o ,  10, 20, 40, 
60, 80 and 100 µL (Fig. A 6. 1) of 3-Hyfroxybutyrate 
standared to tubes containing 100 µL 10% BSA, 300 µL 3 M  
HC104 and double distilled water to a total volume of 
1. 65 mL. 
2. The tubes were vortexed vigorously for 30 sec and 
allowed to sit in an ice water bath for 5 min, vortexed 
again and centrifuged for 10 min at 1500 x g at 2 ° C. 
3. 1 mL of the supernatant was removed and added to another 
to another conical tube on ice. 200 µL of 3 M  KHC03 were 
added and allowed to sit for 15 min, then centrifuged 
for 10 min at 1500 x g at 2 °C. The supernatant was then 
poured off into another tube on ice. 
4. A 100 µL aliquot of the neutralized standard or 
tissue supernatant was added to 1. 9 mL of reaction 
mixture in 4. 5 mL polystyrene Ultra-vu disposable 
80 
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FIGURE A 6 . 1  3-Bydroxybutyrate standard curve 
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cuvette (Baxter Scientific Products, Atlanta, GA) and 
mixed by inversion. 
5. Baseline fluorescence was determined in a Hitachi F-2000 
Fluorescence Spectrophotometer (Exitation 360 and 
Emission 460 nm). 10 µL of BHBDH were then added, the 
cuvettes were mixed by inversion and let sit at room 
temperature for 60 min in the dark. 
6. After 60 min fluorescence was determined again. The 
decrease in fluorescence was proportional to the 
concentration of 3-Hydroxybutyric acid. 
Calculations 
Fluorescence x 1. slope x 5 = nmoles. mL·1 SN 
Fluorescence x !. slope. mg liver = nmoles. mg� liver 
Fluorescence x 1. slope x 10 = nmoles. mg·1 liver 
Reference : 
1. Williamson, D. H. & Meanby, J. (1974) D- (-)-3-
Hydroxybutyrate. In : Methods of enzymatic analysis 
(Bergmeyer, H. U. ed. ), Vol. 4 pp. 1836-1839. Verlag 
Chemie Intl. Deerfild, FL. 
APPENDIX 7 
ACBTYLCAIUfITINB BINDING STUDY 
1 .  SYNTHESIS OF [ 1-14C ]  ACETYLCARNITINE 
Principle 
Carnitine + 14C-acetyl-CoA 
Camitine acyltnm.sferue 
--------------> 14c-acetylcarni tine 
+ Free CoA + 14C-acetyl-CoA 
Anion Exchange 
wacetylcarnitine 
Procedures 
1. Incubate the total volume 3. 5 mL of incubation 
mixture (Table AVII. 1) at 30 °C for 60 min. 
2. Terminate reaction with 200 µL of 36% of perchloric 
acid. 
3. Cool it up and neutralize acidic soup with 300 µL of 
4 N KOH followed by centrifugation. 
4. Take supernatant and pass through anion exchange 
colum (0. 5 x 6 cm) of AG 2- x a ,  c1- form, 200-400 
mash in water. 
5. Elutriate ( 1-wC]  Acetylcarnitine with 3 times with 
0. 5 mL of water. ( yield 85%) 
13 0 
Table A 7.1. 
coapositions of incubation aixture 
Ingredient µ.mol. L-1 µ.mol.mL·1 µ.mol. 3. 5 mL·1 
[ 1-14c J  acetyl-CoA 
( 50 µ.Ci. µ.mole) 171 0.171 0.595 
L-Carnitine 157 0. 157 0. 549 
oxidized Glutathione 5000 5 17.5 
EDTA (EthyleneDiamine 
-TetraAcetate) 1000 1 3. 5 
Potassium phosphate 
(pH = 7.4) 100,000 100 350 
CAT (Carnitine 
Acyl-Transferase) 4 Units 
Reference 
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1. Murthy, M. s. R. & Pande, s. V. (1984) Mechanism of 
carnitine acylcarnitine translocate-catalyzed import of 
acylcarnitines into mitochondria. J. Biol. Chem. 259: 
9082-9089. 
2 .  Binding study 
1. In a 1. 5 mL micro centrifuge tubes (conical bottom 
with attached closure) the total volumes of 0. 5 mL 
contained sodium pyrophospate buffer, pH 7. 4 (55 
mmol. L-1 ) , NAO (0, 1, 2, 4 umol. L-1 ) ,  reduced 
glutathione (1. 1 mmol. L-1 ) ,  [ 1-14C] -acetylcarnitine 
(2 umol. L-1 , specific radioactivity 123, 659 
dpm. nmole or 2061 Bq. nmole), and horse ADH (0. 17 
unit or 100 ug protein). 
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2. The reaction mixture (Table AVII . 2) was incubated for 5 
min at 37 °C in a  Dubnoff metabolic shaking water 
bath (80 oscillation. mi�1 ) .  
3. The reaction mixture was transferred to an 30, 000 
NMWL Ultrafree-MC filter unit (Millipore, Bedford, 
MA) and centrifuged at maximum speed {15, 000 x g) 
for 5 min in an Eppendorf centrifuge, model 5412 · 
(Sybron/Brinkmann Instruments, Westbury, NY). 
4. The residue on membrane sample cup was transferred 
to a scintillation vial containing 5 mL 
scintillation fluid and the radioactivity was 
counted in a Beckman LS 3801 Liquid Scintillation 
counter. 
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Tabla A 7.2 
Incubation mixture for binding study 
Tube No . 1 2 3 4 
Mixture (mL) 
Buffer (pH7 . 4 ) 
75  mmol . L-1 0 . 37 0 . 37 0 . 3 7 0 . 3 7 
NAO 
( 100  µmol . L-1 ) 0 0 . 005 0 . 01 0 . 02 
Reduced 
Glutathione 
( 100 mmol . L-1 ) 0 . 0055 0 . 0055 0 . 0055  0 . 0055  
Horse ADH 
( 100  µg protein 
or 0 . 17 unit) 0 . 01 0 . 01 0 . 01 0 . 0 1 
[ 1-1•c 1 -
acetylcarnitine 
( 12 3 , 659  dpm . nmole 0 . 1 0 . 1  0 . 1 0 . 1 
or 2 0 61  Bq . nmole) 
G . D . W .  0 . 02 0 . 015 0 . 01 0 
APPENDIX 8 
ADB IBBIBITORS 
Inhibitor 
Pyrazol 
4-Metyl pyrazol 
4-Propyl pyrazol 
4-Pentyl pyrazol 
Benz amide 
Isobutyramide 
Auramine 
2, 2, -Bipyridine 
Phenanthroline 
Ki 
0. 22 
0. 013 
0. 004 
0. 000 
530 
14 0 
9 
TABLE A8.1 
Inhibitors of ADH 
competition Mode of action 
Sub. 
It 
It 
It 
Sub . .. 
It 
Cosub. 
It 
Form terary complexes with AOH and NAO 
Heterocyclic ring of pyrazol forms a bridge 
through its two nitrogen atoms and the catalitic 
zinc atom and C-4 of the nicotinamide moiety of 
NAO 
Ternary complexes with AOH and NAOH 
Form strong and specific complexes with AOH 
in the absence and presence of coenzyme 
Bind of AOP-ribose and coenzyme fragments 
Bind to the active zinc atoms and ternary 
complexes (AOH, AOP. ribose, and phenanthroline) 
Imidazoie Sub. & Cosub. Form the binary complexes of ADH and imidazole 
also form ternart complexes (ADH, imidazole, NAO) 
in the presence of coenzyme. 
Primaquine 
Quinoline derivatives 
Amphetamines 
Propranolol 
Folic acid 
Flavensomycin 
metronidazole 
Without characterization of the mode of 
inhibition 
Ref# 
2 
6 
7 
3 
2 
8 
2 
2 
1 
4 
7 
2 
... 
w 
UI 
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